Skip to main content
PLOS Biology logoLink to PLOS Biology
. 2026 Jul 23;24(7):e3003563. doi: 10.1371/journal.pbio.3003563

sept-1/zina-1 is an ancient toxin-antidote system in Caenorhabditis elegans

Dongyao Liu 1, Chaogu Zheng 1,*
Editor: Peter Sarkies2
PMCID: PMC13411925  PMID: 42490680

Abstract

The toxin-antidote (TA) systems, consisting of two tightly linked genes acting as a postzygotic distorter, are found in several eukaryotic organisms, including three androdioecious Caenorhabditis species. However, the evolutionary history of such TA systems remains poorly understood. Here, we report an ancient C. elegans TA system identified in the highly divergent Hawaiian strain XZ1516. The maternal toxin SEPT-1 induces a rod-like larval arrest phenotype in progeny that do not carry the antidote ZINA-1, which has 10 zinc finger motifs. Interestingly, zina-1 is pseudogenized in most non-Hawaiian strains, while sept-1 evolves from a toxic to a non-toxic form through sequence divergence. Phylogenetic studies found that among the three known TA systems sept-1/zina-1 is the most prevalent one in the Hawaiian population that carries the ancestral variants, but it is no longer active in the more derived non-Hawaiian population. The loss of sept-1/zina-1 coincides with the rise of sup-35/pha-1 and peel-1/zeel-1 in non-Hawaiian strains, suggesting dynamic evolution of the TA systems.


Toxin-antidote (TA) systems are found in several eukaryotic organisms, including Caenorhabditisnematodes. This study describes an ancient TA system in C. elegans; the maternal toxin SEPT-1 induces a rod-like larval arrest phenotype in progeny that do not carry the antidote ZINA-1.

Introduction

The toxin-antidote (TA) system is a type of two-component selfish genetic element that promotes its own propagation but does not contribute to the fitness of the host [1,2]. The TA systems were first discovered in prokaryotes with the F-plasmid addiction in E. coli as a well-known example [3]. The plasmid carries a two-gene operon encoding a toxin CcdB that poisons the DNA gyrase and an antidote CcdA that disables the toxin; after cell division, only the daughter cells that inherit the plasmid can survive [4]. So far, hundreds of TA elements with different mechanisms of the toxin-antidote interactions have been found in prokaryotes [5]. In contrast, only a few TA elements are characterized in eukaryotes, including the spore killers in fungi, the gamete-killing meiotic drives in rice, the Medea factors in flour beetles, and the peel-1/zeel-1 and sup-35/pha-1 systems in nematodes [2].

In eukaryotes that undergo sexual reproduction, the TA system often operates by transmitting the toxin into the gametes through the cytoplasm and allowing the toxin to sabotage the development of the gamete or the fertilized egg in the absence of the genomically encoded antidote, which can block the effects of the toxin [6]. As a result, the toxin and antidote are usually coded by two closely linked genes in nearby loci, allowing them to be inherited together. In some surprising cases, they can also be coded by a single gene that exert both toxicity and resistance [6].

The nematode Caenorhabditis elegans has served as an important model organism for the study of the TA systems thanks to the extensive sampling efforts in the past few decades that isolated thousands of wild isolates of C. elegans [7–9]. By crossing the wild strains of C. elegans with the laboratory strain N2, previous studies discovered two pairs of TA elements that exist in N2 but not some wild strains. The peel-1/zeel-1 system encodes a paternal toxin PEEL-1 which is deposited into the sperm and causes embryonic lethality if the offspring does not carry the antidote gene zeel-1 [10,11]. The sup-35/pha-1 system encodes a maternal toxin SUP-35 which is deposited into the oocyte and causes defects in organogenesis and lethality unless the offspring carries the antidote pha-1 [12]. The toxicity and detoxification mechanisms of the two TA systems are not entirely clear, although a recent study found that PEEL-1 is likely a transmembrane cation channel that forms pores to damage the integrity of cell membrane [13]. It is also unclear whether there are more TA elements in addition to the two known ones and whether any wild strain carries TA elements that are not present in the laboratory standard N2 strain.

C. elegans offers tremendous opportunities to discover and understand TA elements in animals because of the availability of numerous wild strains, the ease of doing crosses and genetic manipulation, and the rich information on gene functions through decades of molecular studies. Moreover, self-fertilization of C. elegans to some extent might have prevented the fixation of TA elements in the species, allowing them to be identified through the hybridization of different strains. This idea is supported by recent studies that revealed the potentially widespread presence of TA elements in other self-fertilizing Caenorhabditis species, such as C. tropicalis and C. briggsae [14,15].

Several questions regarding the evolution of the TA systems can be addressed by identifying more TA systems. For example, where do they originate from and what are their evolutionary fate? How are the TA systems gained, maintained, and inactivated or replaced in natural populations? In particular, is the toxin lost mostly through deletion or pseudogenization or can the toxin gene evolve from a toxic to a non-toxic form? Do different TA systems show distinct patterns of ecological distribution? What is their evolutionary relationship? Can multiple TA systems co-exist in the same individuals or instead replace one another during evolution?

In this study, we address the above questions by identifying a novel TA system (named sept-1/zina-1) in a highly diverged C. elegans wild isolate XZ1516. SEPT-1 is a maternally deposited toxin that disrupts the function of the intestine, whereas ZINA-1 is the antidote that blocks the effects of SEPT-1. Interestingly, zina-1 is pseudogenized in N2, while sept-1 was kept and evolved into a largely non-toxic form, as sept-1(N2) only shares 47% identity with sept-1(XZ1516). Phylogenetic analysis showed that sept-1/zina-1 mostly exists in the Hawaiian strains that carry the most ancestral variants. This ancestral TA system disappeared entirely in the non-Hawaiian strains, and its loss coincides with the rise of another maternal TA system sup-35/pha-1.

Results

Genetic mapping of a new toxin-antidote element in a divergent Hawaiian strain

When crossing the laboratory standard Bristol strain N2 with a highly divergent Hawaiian strain XZ1516, we noticed that although the N2/XZ1516 hybrids (F1) developed normally, about ~40% of their progeny (F2) from self-fertilization either died at late embryonic stages or arrested at early larval stages. Two types of larval arrest phenotypes were observed: one showed a rod-like shape, while the other showed a more curled shape with a malformed pharynx (Fig 1A). We then crossed N2 that carried different chromosomal markers with XZ1516 and found that the surviving offspring of the N2/XZ1516 hybrids must carry the chromosome III (chrIII) of N2 and chrV of XZ1516 (Fig 1B–1E), suggesting the presence of two independently segregating TA systems in the hybrid. Between the two identified TA systems in C. elegans [10,12], zeel-1/peel-1 system on chrI is conserved between N2 and XZ1516, but sup-35/pha-1 locus on chrIII shows divergence (S1A and S1B Fig). In the XZ1516 genome, we found inversion and duplication events that led to sequence divergence of the toxin sup-35 and a deletion event that likely inactivated the antidote pha-1. To test whether the preferred inheritance of N2 chrIII was caused by the sup-35/pha-1 locus that was potentially nonfunctional in XZ1516, we deleted sup-35 in N2 carrying a chrIII marker and found that the bias towards N2 chrIII disappeared among the offspring of the N2/XZ1516 heterozygotes (Figs 1F and S1C). The lethality rate dropped to ~25% (Fig 1G) and the arrested larvae all appeared to be rod-like. These results indicated that there remained one other TA element, which was present on the chrV of XZ1516 and absent in N2. This TA system is likely new, since no chrV-associated TA was identified before.

Fig 1. Mapping of a novel TA system in XZ1516.

Fig 1

(A) Arrested larvae among the offspring of N2/XZ1516 hybrids. Type I represents the rod-like arrested larva, while type II represents the curled-up larva with deformed pharynx (arrow). Scale bars, 20 μm. (B, C) Schematic cartoon of the cross and phenotypes of the progeny of the N2/XZ1516 hybrids. Gray bars indicate the N2 chromosomes carrying fluorescent reporters as transgenes, and brown bars indicate the homologous XZ1516 chromosomes. (D, E) Percentages of live or arrested animals that carry the N2-derived fluorescent marker for each chromosome among the progeny of the N2/XZ1516 hybrids. Seventy-five percent animals were expected to carry the dominant marker if it is not linked to the TA system. (F) Percentages of live or arrested animals that carry the N2 chrIII or chrV marker among the progeny of N2[sup-35(unk210)]/XZ1516 hybrids. (G) Percentages of animals that are alive or arrested among the progeny of N2/XZ1516 or N2[sup-35(unk210)]/XZ1516 hybrids. In (D–G), the mean ± SD of 3–5 biological replicates (N ≥ 200 for each) were shown; double asterisks indicate statistically significant (p < 0.01) deviation from the expected 75% for animals carrying the marker or being alive in a Chi-squared test. (H) Whole-genome sequencing results of the near-isogenic lines (NILs) obtained by introgressing the XZ1516-derived TA locus into N2. Reads were mapped to a N2 genome scaffold installed with XZ1516 SNPs and small indels, and the proportion of the reads supporting XZ1516 alleles were plotted. (I) A zoom-in view of the right arm of chrV of a fully assembled XZ1516 genome. Genes in this region were presented as solid dots. The ones that code for proteins with > 100 amino acids, have detectable expression in the XZ1516 transcriptome, and are diverged (< 80% identity) from the N2 genes were marked in red and subjected to RNAi screen. The positive hit is indicated by the arrow. The size of the dots represents mRNA expression levels. The solid line represents the frequency of alternative alleles (N2 is the wild type) in the NILs; bin size is 200 kb. Some images were created in BioRender. Zheng, C. (2026) https://BioRender.com/5fjhayv. The data underlying this Figure can be found in S1 Data.

To understand the inheritance pattern of the new toxin, we crossed hybrid hermaphrodites with N2 males and found arrested larvae in the cross progeny, but the reciprocal cross using hybrid males and N2 hermaphrodites did not produce any arrested animals, suggesting that the toxin is maternally transmitted through the oocyte and its toxicity can be suppressed by a zygotic copy of XZ1516 chrV-linked antidote (S1D and S1E Fig). In the above experiments, we crossed N2 males with XZ1516 hermaphrodites to generate the N2/XZ1516 hybrids. Since previous studies in C. tropicalis found that cross direction can critically affect TA activities [16], we also generated the N2/XZ1516 hybrids by crossing XZ1516 males with N2 hermaphrodites. The same rod-like phenotypes were observed among the progenies of these hybrids, suggesting that this TA is active regardless of whether it is maternally or paternally inherited.

To map the newly found TA system, we introgressed the TA locus into the N2 strain and generated near-isogenic lines (NILs) that carry the XZ1516-derived TA element in the N2 genomic background. Through whole-genome sequencing and SNP mapping (see the Materials and methods for details), we mapped the TA element to a 5-Mb region on the right arm of chrV (Fig 1H). Using a chromosome-level XZ1516 genome, we predicted genes in this region and a nearby 2-Mb region (Chr V: 15–22 Mb in total) and found 458 genes that code for proteins longer than 100 amino acids and had detectable mRNA expression (FPKM > 0) in the transcriptome (Fig 1I). From these genes, we compiled a list of 46 candidate genes with low or no homology (< 80% identity) with N2 genes, assuming that the TA element is absent or highly diverged in the N2 strain (S1 Table). We then created RNAi constructs expressing dsRNA against these candidate genes and transformed them into bacteria to allow the delivery of the dsRNA into XZ1516 strain through feeding RNAi. We expected silencing of the antidote gene to cause lethality in XZ1516 due to the unsuppressed toxicity from the toxin.

From this RNAi screen, we identified only one gene, whose knockdown led to the rod-like larval arrest phenotype similar to the arrested offspring of the N2/XZ1516 hybrid (S2A Fig). Synteny analysis showed that this gene was aligned to the N2 pseudogene B0250.4 (Fig 2A). In XZ1516, it is a 15-exon gene encoding a 548-amino acid protein with 10 C2H2-type zinc finger motifs, so we named this gene zina-1 for “zinc finger-containing antidote 1”. Sequence alignment suggests that zina-1 is pseudogenized in N2 due to the deletion of exon 3, intron 3, and part of exon 4, leading to a frameshift and premature stops (Fig 2B). The rest of the exons have very high identity (>95.6%) between zina-1 and N2 B0250.4, denoted as zina-1(N2ψ), although there are still some missense variations (Fig 2B).

Fig 2. Identification of zina-1 as the antidote gene and sept-1 as the toxin gene.

Fig 2

(A) A zoom-in view of the potential TA locus in XZ1516 and its comparison with N2 genome. F108508-F108511 were de novo annotated by Funannotate. (B) zina-1(XZ1516) contains 15 exons and is pseudogenized in N2 due to the deletion of exon 3 and part of exon 4, which led to frameshift and premature stop codons (in red) from exon 3 onward. zina-1 in XZ1516 codes for a 548 a.a. protein with 10 zinc finger motifs. In addition to the deletion in N2 (dashed line), the ZINA-1 coding sequence carries many missense variants (color-coded by BLOSUM distance) in N2 compared to XZ1516. (C) RNA reads supporting the exons of F108510 and F108511 were shown. sept-1 long isoform contains a 5′UTR formed by five noncoding exons and its short isoform has only one noncoding exon. It shares 47% identity and 67% similarity with B0250.8 in N2. SEPT-1 is a 166 a.a. protein with a putative SEP domain (based on similarity with C. elegans UBXN-2). Molecular lesions of various unk alleles were shown. (D) Rates of lethality caused by RNAi against zina-1, sept-1(XZ1516), and sept-1(N2) in various strains (N ≥ 100 for each data point). Double asterisks indicate statistically significant (p < 0.01) deviation from 0% (found in XZ1516 and N2 controls) in a Chi-squared test. (E) Percentages of arrested animals among the progeny of the hybrids between XZ1516 sept-1 mutants and N2 sup-35(-). (F) Percentages of live animals carrying chrIII or chrV markers among the progeny of the hybrids between XZ1516 sept-1 mutants and N2 sup-35(-). In (E, F), the mean ± SD of 3–4 biological replicates (N ≥ 100 for each) were shown; double asterisks indicate statistically significant (p < 0.01) deviation from the expected 75% for animals being alive or carrying the marker in a Chi-squared test. The data underlying this Figure can be found in S1 Data.

Identifying a SEP domain-containing protein SEPT-1 as the toxin in the TA element

We next searched for the toxin gene based on the assumption that the toxin is closely linked to the antidote. Homology-based annotation identified srd-70, B0250.18, calf-1, rpl-2, dhcr-7, and srbc-79 in the genomic region flanking zina-1, but they are all highly similar between N2 and XZ1516 and not likely to be the toxin. We then used Funannotate [17] to perform de novo gene prediction and identified four additional protein-coding genes (F018508 to F018511) in this region. F018508 had no supporting RNA-seq reads, and F018508 showed homology with N2 rpl-2. F018510 showed homology with N2 B0250.8, while F018511 overlapped with calf-1. Since there are RNA-seq reads connecting F018510 and F018511, we used forward primers that bind to spliced leaders (SL1 and SL2) and reverse primers that bind to F018510 exon 3 to obtain full-length transcripts of F018510 and indeed found two isoforms containing exons from F018511 (Fig 2C). Nevertheless, these exons appeared to be noncoding and likely serve as 5′UTR. Based on RNA-seq reads, the long isoform is the minor isoform (S2C Fig).

We then deleted F018510 coding sequence in XZ1516 and conducted RNAi against the antidote zina-1 in the knockout mutants (unk192) and did not observe any arrested larvae. In contrast, deleting four exons encoding the 5′UTR of the long isoform (unk194 allele) did not affect the lethality in zina-1 RNAi animals (Fig 2D). These results suggest that F018510 codes for the toxin. Since both XZ1516 F018510 and N2 B0250.8 code for proteins with a putative SEP domain, we named the F018510 gene sept-1 for “SEP domain-containing toxin 1”. In the following text, we refer to the B0250.8 gene in N2 as sept-1(N2), which is highly diverged from sept-1(XZ1516) with only 47% identity. Since the antidote is pseudogenized in N2, we hypothesize that the presumptive toxin sept-1 may no longer be toxic in N2 due to either functional divergence or loss of expression. The function of SEP domain is currently unclear, although one study suggests that it may inhibit lysosomal cysteine protease cathepsin L [18]. SEP domain is almost always followed by a UBX domain in proteins, and indeed, the sequence following the SEP domain in SEPT-1 is aligned to C. elegans UBXN-2 (Fig 2C).

To further confirm that sept-1 is the toxin, we crossed XZ1516 sept-1(unk192) with N2 sup-35(-) and found that since both toxins are removed, the preference for N2 chrIII and XZ1516 chrV was eliminated among the offspring of the hybrids, and the fluorescent markers on both chromosomes were normally inherited by 75% of the progeny (Fig 2E and 2F). To further confirm that the SEPT-1 protein and not its mRNA is toxic, we created three alleles (unk215, unk219, and unk220) that only deleted the start codon of sept-1 and a few flanking nucleotides (S2B Fig) and found that they indeed removed the maternal toxicity of the N2/XZ1516 hybrids (Fig 2E and 2F).

After mapping the TA system, we used genotyping as a more accurate method to confirm its inheritance pattern. First, in the XZ1516 background, deleting the TA on the chrV led to the loss of that chromosome in surviving offspring of the heterozygotes; the same is true for the N2/XZ1516 hybrid and the N2 backgrounds (S3A Fig). Thus, the TA element mandates its own propagation regardless of the genetic environment. Second, we confirmed that the toxin was maternally deposited into the oocytes and paternal inheritance did not cause any lethality (S3B Fig).

While we were conducting this work, the Kruglyak lab reported a TA system in XZ1516, which was discovered by crossing it with the QX1211 strain [19]. They named the system mll-1/smll-1, which is the same as the sept-1/zina-1 locus. However, our characterization of this TA system differs significantly from theirs (see below).

ZINA-1 activity is lost and SEPT-1 toxicity strongly attenuated in N2

Since zina-1(N2ψ) appeared to be pseudogenized by a deletion of exon 3 and 4, we repaired the locus by inserting a 190-bp fragment of zina-1 coding sequence to restore the open reading frame (S4A Fig). Surprisingly, this repaired allele, denoted as zina-1(N2*), did not provide any protection against sept-1 toxicity, as none of the surviving offspring of N2/XZ1516 hybrid carried the allele (Fig 3A). We also used extrachromosomal array to overexpress zina-1(N2*) from either the zina-1(N2ψ) promoter or the XZ1516 zina-1 promoter; neither array was able to inhibit the maternal SEPT-1 (Fig 3A and 3B). As controls, we expressed zina-1 from the two promoters and both were able to protect the animals that do not carry the antidote gene in the genome (Fig 3C). This result suggests that the missense mutations in zina-1(N2*) may have rendered the protein inactive even if the deletion did not occur. In fact, many mutations affected residues in the zinc finger domains, potentially disrupting functions (Fig 2B).

Fig 3. SEPT-1(XZ1516) proteins are more toxic than SEPT-1(N2).

Fig 3

(A) Percentages of live animals with specific genotypes (determined by single-worm PCR) among the progeny of N2/XZ1516 hybrid that carry the repaired zina-1(unk232) allele from N2, denotated as zina-1(N2*), or extrachromosomal arrays expressing zina-1(N2*). It should be noted that the zina-1(N2*) expressed from zina-1p(N2) contained all the variants from the exon 3 and 4 of XZ1516. (B) Schematic cartoon of the experiments. Only live progeny that carried the extrachromosomal array were subjected to genotyping. (C) Percentages of live animals with specific genotypes among the progeny of N2/XZ1516 hybrid carrying the indicated extrachromosomal arrays. Mean ± SD of 3 biological replicates (N ≥ 50 for each) were shown (the same for E). Double asterisks indicate statistically significant deviation (p < 0.01) from the expected 2:1 ratio for TA(+/-):TA(+/+) in a Chi-square test. (D) Percentages of L1 animals (in N2 background) carrying the unkSi32[hs::sept-1(XZ1516)] and unkSi18[hs::sept-1(N2)] that were still alive at 24 hours after a 5, 15, 25, 35, 45, and 55-min heat-shock. Representative images of unkSi32 animals that were arrested after a 45-min heat-shock (scale bars, 20 mm). Three to five replicates (N ≥ 100) were carried out; double asterisks indicate significant difference (p < 0.01) between two curves in a Kolmogorov–Smirnov test. Two independent lines were tested and similar results were obtained. (E) Percentages of live animals with the indicated genotypes among the progeny of N2/XZ1516 hybrid that carry the wild-type sept-1(XZ1516) or sept-1(unk223), which is sept-1(XZ1516)p::sept-1(N2), or sept-1(unk243), which is sept-1(XZ1516)p::sept-1(N2)_recode, from XZ1516. (F) The predicted piRNA binding sites in the coding region of sept-1(N2), which were mutated in the sept-1(N2)_recode version. Red letters indicate the synonymous mutations. (G) Percentages of animals that were arrested in N2 carrying the sept-1(N2; unk277, recode) or sept-1(N2; unk257) allele, which is sept-1(N2)p::sept-1(XZ1516), and subjected to various RNAi treatment. All animals carry the zina-1(unk232, N2*) background. Double asterisks indicate statistically significant (p < 0.01) deviation from 0% for larval arrest in a Chi-squared test; N ≥ 100 for each of the five replicates. (H) The same as (G) except the animals also carry prg-1(n4503) alleles. Details of the alleles used in this Figure can be found in S4 Fig. The data underlying this Figure can be found in S1 Data.

A puzzling issue of the sept-1/zina-1 system is that the toxin is kept in N2 where the antidote is lost. To assess and compare the toxicity of SEPT-1(XZ1516) and SEPT-1(N2) proteins, we used the MosTI approach [20] to construct animals carrying a single-copy transgene that expressed sept-1(XZ1516) or sept-1(N2) from a heat-shock promoter in N2 at exactly the same genomic locus (S4B Fig). Heat induction (at 33 °C) of 30 min produced little lethality with SEPT-1(N2), whereas the same condition caused almost 100% lethality by SEPT-1(XZ1516) (Fig 3D). Although prolonged induction of SEPT-1(N2) expression could still cause larval arrest, its toxicity was much weaker than SEPT-1(XZ1516) in the N2 background. Using RT-qPCR, we found that the heat-shock promoter induced similar mRNA expression of sept-1(N2) and sept-1(XZ1516) (S5A Fig), but western blot results indicated that the same heat-shock condition resulted in higher expression of SEPT-1(XZ1516) proteins than SEPT-1(N2) (both are fused with HA-tags; S5B Fig). We reason that the SEPT-1(N2) proteins may be less stable than SEPT-1(XZ1516), which could contribute to the lower toxicity. Forced expression of sept-1(XZ1516) resulted in less lethality in L4 animals than in L1 animals, suggesting that older animals are more resistant to sept-1 toxicity (S5C Fig). Nevertheless, we still observed significantly weaker toxicity from sept-1(N2) compared to sept-1(XZ1516). When examining the arrested animals after the heat-shock, we noticed that they had thinner intestine than wild-type animals, and the phenotype was more pronounced in animals carrying the hs::sept-1(XZ1516) transgene than the ones carrying hs::sept-1(N2) (S5D Fig). This result suggested that somatic expression of the toxin may disrupt the function of the intestine.

To test the potential toxicity of SEPT-1(N2) in the XZ1516 background, we swapped out sept-1(XZ1516) coding region with sept-1(N2) sequences in the XZ1516 genome and crossed the edited XZ1516 with N2 (S4C Fig). We did not observe any lethality among the offspring of the hybrid and the edited TA elements followed the Mendelian segregation pattern (Fig 3E), suggesting that sept-1(N2) has no toxicity if expressed from the endogenous sept-1(XZ1516) promoter. We reason that SEPT-1(N2) has lost most of its toxicity due to protein sequence divergence, which allows zina-1 to be pseudogenized by genetic drift.

The report by Zdraljevic and colleagues from the Kruglyak lab suggests that sept-1(N2) (referred to as B0250.8 in their paper) is not toxic because its expression in N2 is suppressed by small RNAs [19]. Specifically, they propose that piRNA binding to the sept-1(N2) transcripts would lead to perpetual silencing by the 22G endo-siRNA pathway [19]. To formally test this idea, we replaced the sept-1(N2) coding region with recoded sequences that altered most codons through synonymous mutations. This recoding likely removed the potential piRNA binding sites in the coding sequence and would, in theory, allow sept-1(N2) to be expressed and its possible toxicity to be tested (Fig 3F). In fact, using RT-PCR we were able to detect the expression of the recoded sept-1(N2), while wild-type sept-1(N2) was not detectable. However, we did not observe any larval arrest phenotype in the recoded animals (Fig 3G). Since we did the gene editing in the zina-1(N2*) background, we also knocked down zina-1 and did not observe any lethality either. To further rule out the effects of piRNAs, we crossed the above animals with prg-1(-) mutants (prg-1 codes for the only Piwi-family Argonaute [21] in C. elegans) but still did not find any lethality caused by sept-1(N2) (Fig 3H). Moreover, we created animals that expressed the recoded sept-1(N2) from the endogenous sept-1(XZ1516) promoter in XZ1516 and crossed the edited XZ1516 with N2 and did not find arrested larvae among the progeny of the N2/XZ1516 hybrids (Figs 3E and S4C). Thus, we concluded that the lack of toxicity from the sept-1(N2) locus is not likely due to small RNA-mediated mechanisms but rather the non-toxic nature of the SEPT-1(N2) protein.

As a control, we replaced the sept-1(N2) coding region with sept-1(XZ1516) sequences and indeed observed rod-like arrest phenotype in ~15% of the animals, supporting the idea that sept-1(XZ1516) is more toxic than sept-1(N2) (Fig 3G). Interestingly, the lethality caused by sept-1(XZ1516) expressed from the sept-1(N2) locus was enhanced in the prg-1(-) background (Fig 3H). We reason that there may be some small RNAs targeting the sept-1(XZ1516) coding region or the unaltered sept-1 UTR region in N2.

3′UTR of the sept-1 mRNA has a stem-loop structure and is A-to-I edited

We next studied the expression pattern of the toxin and antidote. First, we designed single-molecule fluorescent in situ hybridization (smFISH) probes against sept-1 mRNA, but could not detect any signal in the gonad or in early embryos of XZ1516 animals. We then created an endogenous TagRFP knock-in at the sept-1 locus in XZ1516 but failed to observe any TagRFP signals in early embryos. Antibodies staining against the HA tag fused to the C-terminus of the SEPT-1::TagRFP did not generate any signal either. Surprisingly, the smFISH against sept-1(XZ1516) coding sequence gave some signals in the gonad of sept-1(XZ1516)::TagRFP animals (Fig 4A). These results might suggest that the sept-1 mRNA but not proteins are maternally deposited into the oocyte. Our finding is generally consistent with the report by Zdraljevic and colleagues [19], although they were able to directly detect the presence of sept-1 transcripts with smFISH in the early embryos of XZ1516.

Fig 4. sept-1(XZ1516) 3′UTR forms a hairpin structure and undergoes A-to-I editing.

Fig 4

(A) smFISH signal against the sept-1(XZ1516) coding region in dissected gonads of the wild-type, sept-1(unk247; sept-1::TagRFP), and sept-1(unk192) XZ1516 adult animals. Scale bars, 20 μm. sept-1(unk192) is the sept-1(-) allele and serves as a negative control. The dashed boxes are enlarged in the bottom images. (B) A schematic cartoon showing the difference between the mRNAs produced by wild-type sept-1(XZ1516) and sept-1(unk247; sept-1::TagRFP) loci. The short blue lines indicate the smFISH probes. (C) A schematic presentation of the positions of A-to-I editing in the stem structure of the sept-1 3′UTR based on published RNA-seq results (NCBI SRA: SRR12868314). Each asterisk indicates one edited nucleotide. The number of steps on the ladders does not accurately reflect the number of base pairings in the hairpin; the scheme is intended to show the rough positions of the edits. (D) Percentages of RNA reads that show the A-to-I editing (read as a G) for each edited site for XZ1516 wild-type and adr-2(unk280) animals based on the RNA-seq data generated in this study. Two biological replicates identified 48 and 43 edited sites, respectively, in XZ1516 wild-type animals; no editing was found in adr-2 mutants. The data underlying this Figure can be found in S1 Data.

We do not know why our sept-1(XZ1516) probes did not produce any signal in wild-type XZ1516 animals, but upon close inspection of the sept-1(XZ1516) mRNA sequence, we found a very long stem-loop structure in the 795-nt 3′UTR region (Fig 4B). The entire 3′UTR of sept-1(XZ1516) is mostly a palindromic sequence that folds into a hairpin structure with a 315-nt-long stem and a 7-nt unpaired loop according to a structure predicted by “RNA fold” (http://rna.tbi.univie.ac.at/cgi-bin/RNAWebSuite/RNAfold.cgi). In comparison, the coding region of sept-1 is merely 501-nt-long. Thus, we speculate that the proximity to the hairpin-structured 3′UTR may somehow render the sept-1(XZ1516) coding sequence inaccessible by the smFISH probes but inserting a 711-nt-long TagRFP sequence between the sept-1 coding and 3′UTR regions might free up the coding region for the binding by the smFISH probes (Fig 4B).

Interestingly, when examining the published RNA-seq data (NCBI SRA: SRR12868314) of XZ1516, we found 31 “G to A” mismatches between the mRNA sequence and the genomic sequences in the sept-1(XZ1516) 3′UTR (Fig 4C). Even more mismatched sites were identified from the RNA-seq data generated in this study (Fig 4D). Since inosine (I) is typically read as a guanine (G) in DNA sequencing, we concluded that the sept-1(XZ1516) 3′UTR underwent extensive A-to-I editing, and this editing appeared to occur as clusters in the double-stranded region of the 3′UTR on both the ascending and descending arms of the stem (Fig 4C). Previous studies found that A-to-I editing by adenosine deaminases (ADARs) enhanced the mRNA levels of germline and neuronal genes [22,23]. We found that the sept-1(XZ1516) mRNA levels only decreased by 5% (not significant) in adr-2(-) mutants, which deleted the only active adenosine deaminase in C. elegans [23] and removed all mismatches of RNA to DNA sequence in sept-1 3′UTR (Fig 4D). Moreover, the loss of A-to-I editing did not affect sept-1 toxicity, since zina-1 RNAi in the adr-2(-) mutants still resulted in rod-like larval arrest. Thus, the editing of sept-1(XZ1516) RNA is not essential for its expression and toxicity.

Single-copy sept-1(XZ1516)p::mScarlet3 and sept-1(N2)p::mScarlet3 transcriptional reporters did not show any fluorescent signals, so we generated multicopy extrachromosomal arrays for these reporters instead. Since the arrays were known to be often silenced in the germline [24], we only detected somatic expression of sept-1(XZ1516) and sept-1(N2) in the pharynx and intestine (S6 Fig). The expression level of sept-1(XZ1516) appeared to be much higher than sept-1(N2) in both XZ1516 and N2 backgrounds, suggesting that sept-1(XZ1516) promoter has stronger activity compared to sept-1(N2) promoter likely due to considerable sequence divergence (49.3% identity for the 2-kb promoter region). Although somatic expression of the toxin is not necessary for the propagation of a classical TA, it remains unclear whether the expression of sept-1 in the digestive tract enhances its toxicity or has other functions.

ZINA-1 protects the development of the intestine by suppressing the SEPT-1 toxicity

To examine zina-1 expression, we constructed both transcriptional and translational GFP reporters of zina-1 in XZ1516. Widespread expression was detected in the embryos as early as gastrulation and proceeded through comma stages. The GFP::ZINA-1 translational fusion showed enrichment in the developing E lineage which was marked by ges-1p::TagRFP and formed the intestine (Fig 5A). In L1 and adult animals, we observed zina-1p::GFP and zina-1p::GFP::zina-1 expression mostly in the pharynx and intestine (Fig 5B). The difference in the GFP signals between the transcriptional and translational reporters may reflect the instability of the antidote protein, which was found in other TA systems as well [25].

Fig 5. zina-1 suppresses sept-1 toxicity in the intestine.

Fig 5

(A) The expression of zina-1 transcriptional and translational reporters in the embryos at gastrulation and comma stages. The E lineage that forms the intestine is labeled by TagRFP expressed from ges-1 promoter. (B) The expression of zina-1 reporters at L1 and adult stages. The pharynx part of the adult image of zina-1p::GFP::zina-1 is enlarged in the box. (C) Representative DIC images of a wild-type N2 larva at L1 stage and an arrested larva among the progeny of the N2/XZ1516 hybrid. Dashed boxes are enlarged in the inserts showing the shrinkage of the intestine in the arrested larva. (D, E) Wild-type N2 larva and arrested larva among the F2 progeny of the N2/XZ1516 hybrid carrying the caIs71[elt-2p::GFP::HIS-2B; rol-6(D)] and the jyIs13 [act-5p::GFP::act-5] transgenes, respectively. Scale bars represent 20 μm in all panels.

The enrichment of ZINA-1 in the digestive system in XZ1516 led us to hypothesize that ZINA-1 may mostly function in the intestine to detoxify SEPT-1. In fact, when we examined the arrested larva caused by the SEPT-1 toxicity, we observed abnormal intestinal morphology under the differential interference contrast microscopy, as the intestinal cells became thinner and separated from the body wall muscles (Fig 5C). The arrested larva among the progeny of N2/XZ1516 hybrids also appeared to have bloated intestine, indicating digestion failure. Although the number of intestinal cells (labeled by elt-2p::GFP::H2B) were largely normal in the arrested animals, we confirmed the appearance of bloated intestinal lumen using GFP::ACT-5 that labels the apical domain of the intestinal cells (Fig 5D and 5E). These results indicated that intestinal development and/or function is disrupted by SEPT-1 in the absence of ZINA-1.

To confirm ZINA-1 functions in the intestine, we constructed extrachromosomal array that expressed zina-1 from the intestine-specific ges-1 promoter in N2 and crossed the animals with XZ1516. We found that if the offspring of the N2/XZ1516 hybrids carried the extrachromosomal array, they can survive even if they did not have XZ1516 chrV (Fig 3C). In contrast, pharyngeal expression of zina-1 from the myo-2 promoter in the extrachromosomal array could not protect the animals that did not carry the genomic zina-1 (Fig 3C), suggesting that ZINA-1 must act in the intestine to detoxify SEPT-1.

Distribution of the three TA systems among the wild populations of C. elegans

The fact that N2 and XZ1516 can poison each other using two different maternal TA systems prompted us to examine the distribution of the three known TA systems in the global population of C. elegans. We created a computational pipeline to map the presence and absence (or divergence) of the peel-1/zeel-1, sup-35/pha-1, and sept-1/zina-1 systems among 611 wild isotypes, which were divided into 24 groups based on unique genotypes for toxins and antidotes and positions on the phylogenetic tree (Figs 6A and S7; S2 Table; see Materials and methods for details). The tree was built using 4,736 single-copy genes defined by previous studies [26] and showed the clustering of Hawaiian strains, which were known to carry ancestral variants [8,27], and the non-Hawaiian strains, which carry more derived alleles. Among the Hawaiian strains (groups 1–14), the sept-1/zina-1 system is the most prevalent (Fig 6B), suggesting that sept-1/zina-1 may be the most ancestral TA system among the three. Moreover, we also observed the potential transition from sept-1(XZ1516) to sept-1(N2) in the Hawaiian strains, as three strains (ECA2949 from group 5, ECA2452 from group 13, and ECA2968 from group 14) carry both sept-1(XZ1516) and sept-1(N2) alleles. In those strains, sept-1(N2) remains linked to zina-1, while sept-1(XZ1516) is on a small contig that does not contain any other gene. Thus, we suspect that a duplication event created two copies of sept-1(XZ1516); one copy accumulated mutations and became the non-toxic sept-1(N2), while the other moved out the locus and was subsequently lost. Many Hawaiian strains carried only sept-1(N2) (e.g., group 12) or no elements from any of the three TA elements (e.g., group 6). The above results led to a model that sept-1/zina-1 is an ancestral TA system that was gradually lost during the evolution of C. elegans. In fact, in the non-Hawaiian population (groups 15–24), not a single strain carries sept-1/zina-1, while many carry either sup-35/pha-1 or peel-1/zeel-1 or both (Fig 6B).

Fig 6. Evolutionary history of the three TA systems in C. elegans.

Fig 6

(A) A phylogenetic tree of representative wild isotypes from 24 groups with unique genotypes of the three TA systems. This tree is extracted from a bigger phylogenetic tree of 611 C. elegans wild isotypes (S7 Fig) constructed using optimal comminated bayes models selected by ModelFinder [39]. Strains that were physically isolated from Hawaiian Islands are labeled in orange. The number of strains from each group is labeled in paratheses. Some groups contain both Hawaiian (HI) and non-Hawaiian strains (non-HI); the identity of the group is determined by the majority of the strains, and the number of minority strains were also indicated in the paratheses. Strain information for each group is shown in S2 Table. The genotypes for both the toxin and antidote in the three TA systems were annotated (see Materials and methods for the details of genotype calling). “N.D.” means “not determined” since the genotype is missing. (B) The overlapping among the three functional TA systems in the Hawaiian and non-Hawaiian populations were shown in the Venn diagrams. The number of strains that carry the corresponding TA system is shown.

While inspecting the genomes of the wild isolates, we noticed a few unexpected cases where the toxin is preserved but the antidote is lost. For example, in six strains (groups 4, 10, and 17) peel-1 can be found but zeel-1 is pseudogenized or lost. Among the six strains, the four Hawaiian ones (ECA701 from group 4; ECA1769, ECA2091, and ECA2191 from group 10) all carry a F97Y variant in peel-1. So, one hypothesis is that this substitution might render PEEL-1 non-toxic. Interestingly, XZ1516 and other Hawaiian strains also carry the F97Y variant, questioning whether peel-1 exerts toxicity in Hawaiian strains. For the non-Hawaiian JU1652 and NIC166, we found no nonsynonymous mutations in peel-1 despite the loss of zeel-1. Either the antidote annotation is incorrect due to low genome quality, or an alternative detoxification mechanism exists. The same applies for the four strains (ECA2183 and ECA2960 from group 2, ECA2452 from group 13, and ECA2968 from group 14) that carry sept-1(XZ1516) and pseudogenized zina-1.

For sup-35/pha-1, previous work suggested that pha-1 was deleted and sup-35 was pseudogenized in the DL238 strain leading to the maternal-effect incompatibility with the N2 strain. Upon close inspection of the assembled genome of DL238, we found an open reading frame for sup-35, and the predicted SUP-35(DL238) proteins showed significant sequence divergence from the SUP-35(N2) protein (42.9% identity and 57% similarity; S8A and S8B Fig). Phylogenetic reconstruction indicated that sup-35 is likely derived from a tandem duplication of the nearby Y48A6C.4, which is a paralog of the rmd genes (especially rmd-1 and rmd-2) (S8C Fig). In strains like N2, this duplication led to the formation of the toxin SUP-35, whereas in strains like DL238, the duplicate gene had accumulated variants that render it non-toxic. In XZ1516, complex duplication and rearrangement led to three copies of Y48A6C.4 and three copies of sup-35, which are all diverged from sup-35(N2) (S1B and S8C Figs). The above results mirror the effect of sequence divergence between SEPT-1(XZ1516) and SEPT-1(N2) and led us to hypothesize that accumulation of missense mutations in the toxin gene may be a common way to disable its toxicity while potentially maintaining its other functions.

sept-1/zina-1 system is a C. elegans-specific innovation

To investigate the evolutionary origin of the sept-1/zina-1 TA system, we searched for homologous sequences across the nematode genomes related to C. elegans using BLASTN and BLASTP but did not find any significant homolog for either sept-1 or zina-1. We then created multispecies alignment to examine the syntenic evolution of the locus harboring sept-1/zina-1 and found that this genomic region is conserved cross most species but shows divergence in C. elegans and C. inopinata (Fig 7A). sept-1/zina-1 appears to be a C. elegans-specific genomic innovation. Despite the broken synteny, three genes (calf-1, rpl-2, and dhcr-7) in this region are conserved throughout all species. Using the genomic sequences of these three anchor genes, we constructed a phylogenetic tree to show the evolutionary history of this TA-bearing region. The topology of the tree places the XZ1516 haplotype next to other sister species and the N2 haplotype within the C. elegans lineages, suggesting that the XZ1516 haplotype represents a more ancestral state than the N2 haplotype (Fig 7B). This finding supports that sept-1/zina-1 is an ancestral TA system that is subsequently inactivated in more derived lineages.

Fig 7. sept-1/zina-1 is an ancestral TA system in C. elegans.

Fig 7

(A) The genomic region homologous to the C. elegans region that contains sept-1/zina-1 in selected Caenorhabditis species were shown. Conserved genes with public names were labeled. Despite the divergence in C. elegans and C. inopinata, all genomes contain calf-1, rpl-2, and dhcr-7 in this region. (B) A phylogenetic tree built by IQ-TREE with maximum likelihood method using the concatenated calf-1, rpl-2, and dhcr-7 genomic sequences from the selected Caenorhabditis species and C. elegans wild isolates. The genomes of the wild isolates were assembled using the long-read sequencing results. (C) A phylogenetic tree based on zina-1 coding sequences. Four haplotypes were illustrated on the right; the number of strains represented by the haplotype is indicated in the paratheses. XZ1516 carries the haplotype with sept-1(XZ1516) and reference zina-1. ECA1409 and ECA1717 carry one missense mutation in zina-1. ECA1194 represents a haplotype in which sept-1 is deleted. In most strains of this group, zina-1 were pseudogenized by a premature stop (Y154*). In ECA1194, the first four exons of zina-1 were not covered by the short reads and were thus depicted in gray. The ECA2367 and N2 haplotypes carry many missense variants in zina-1. The ones shared by both were shown as red dots, and the one specific to each were labeled by gray dots and spelled out. Fig 2B also showed the missense variants in zina-1(N2ψ).

In addition to the N2 haplotype in which sept-1 is diverged and zina-1 is pseudogenized by an internal deletion, we identified two other haplotypes for the sept-1/zina-1 locus (Fig 7C). One carries the sept-1(N2) allele and a functional open reading frame for zina-1 without the deletion of exon 3 and 4. However, this zina-1(ECA2367) allele carries most of the missense variants found in zina-1(N2ψ), indicating that the accumulation of missense mutations in zina-1 occurred before the frameshift-inducing deletion. Given that adding the deleted sequences back into zina-1(N2ψ) did not restore its detoxification ability (Fig 3A), we suspect that zina-1 has already lost its function before the internal deletion that pseudogenized the gene. This is expected, since the toxin sept-1 has already evolved to the non-toxic sept-1(N2) allele in this haplotype. Another haplotype (e.g., in ECA1194) showed the deletion of sept-1, suggesting an alternative way of inactivating the sept-1/zina-1 TA system.

Discussion

In this study, by crossing the laboratory N2 strain with the highly diverged Hawaiian XZ1516 strain, we identified a new TA system in XZ1516 and named it sept-1/zina-1. This TA system is the same as the mll-1/smll-1 system identified by Zdraljevic and colleagues, in a recent study that crossed XZ1516 with QX1211 strain [19]. We and their studies independently mapped the TA system to the same region on the right arm of the XZ1516 genome and showed that the toxin is maternally transmitted into the oocyte likely through the deposit of toxin mRNA. We and their studies both found that the toxin has a homolog B0250.4 or sept-1(N2) in the N2 strain, while the antidote is pseudogenized. However, our explanation of this unusual evolutionary pattern differs.

The study by Zdraljevic and colleagues suggests that sept-1(N2) is not toxic because its expression is suppressed by secondary 22G siRNAs generated by the primary piRNA targeting the sept-1(N2) transcripts [19]. In contrast, our work indicate that the toxicity of the SEPT-1(N2) is significantly attenuated by protein sequence divergence to the point that the presence of the antidote is no longer required for the survival of the animals in the N2 strain. Even when the small RNA-mediated suppression of the sept-1(N2) is removed through recoding the sequence or mutating prg-1, we still did not observe any rod-like arrested larva. Moreover, when expressed from the sept-1 locus in XZ1516 background, sept-1(N2) did not cause any lethality either in its original or recoded sequences, supporting that the SEPT-1(N2) protein is non-toxic. Our findings suggest that even if sept-1(N2) is targeted by the endogenous small RNAs, the suppression of its mRNAs is not likely the major reason for the lack of toxicity in the absence of the antidote. Instead, the divergence of the actual protein sequences (only 47% identity) between SEPT-1(XZ1516) and SEPT-1(N2) counts for most of the differences in toxicity. Interestingly, the coding sequence of SUP-35 proteins in DL238, XZ1516, and other strains also differs from that of the toxic N2 form, which may explain the lack of toxicity in those strains. Nevertheless, it remains unclear whether sup-35 evolved from a nontoxic form to a toxic form or the other way around.

In addition, the promoter of sept-1(XZ1516) appears to be stronger than the sept-1(N2) promoter, and the stem-loop structure in sept-1(XZ1516) 3′UTR might help promote the stability and facilitate the translation of the sept-1(XZ1516) mRNA, as the 3′-terminal stem-loop is known to do so [28]. On the contrary, sept-1(N2) does not have a similar 3′UTR. Moreover, SEPT-1(N2) proteins may be less stable than SEPT-1(XZ1516). Thus, we concluded that multiple mechanisms enabled the evolution of the sept-1 locus from a toxic allele in XZ1516 into a non-toxic allele in N2.

The larval arrest phenotype caused by SEPT-1 toxicity is morphologically similar to a previously reported rod-like larval lethal phenotype found in mutants of Ras pathway genes [29]. However, the rod-like lethality in Ras mutants were caused by defects in the development or function of the excretory system (leading to the buildup of fluids in the body), whereas SEPT-1-induced lethality appears to be caused by defects in the intestine. Thus, different mechanisms may have led to the same rod-like phenotype.

Although the function of SEPT-1 and how it poisons the intestine are unknown, the antidote ZINA-1 has 10 clearly defined zinc finger motifs. Since ZINA-1 is not localized in the nucleus, we suspect that it may not be a DNA-binding protein and is instead an RNA-binding protein. One appealing hypothesis is that ZINA-1 may block the effects of SEPT-1 by binding to the sept-1 mRNA. The long hairpin structure of the sept-1 3′UTR may be a potential binding site for ZINA-1. Nevertheless, we cannot rule out the possibility that ZINA-1 may function in an RNA-independent manner, as many zinc finger proteins do [30].

Our phylogenetic analysis uncovered an evolutionary history of the three known TA systems in C. elegans. We found that the sept-1/zina-1 is the most prevalent TA in the Hawaiian strains carrying the most ancestral variants of the species. The deletion of sept-1 or the transition from the toxic form to a non-toxic allele through accumulation of missense mutations, accompanied by zina-1 pseudogenization, were observed in the more derived Hawaiian strains. This result suggests that sept-1/zina-1 was already inactivated in the Hawaiian population. Coinciding with the loss of sept-1/zina-1, another maternal TA sup-35/pha-1 and the paternal TA peel-1/zeel-1 started to propagate. In fact, majority of the strains in the non-Hawaiian population carry either sup-35/pha-1 or peel-1/zeel-1 or both, and none of them carries active sept-1/zina-1. Interestingly, four Hawaiian strains (group 3 in Fig 6A) contain all three known TAs, which echoes previous findings that some C. tropicalis isolates could carry multiple maternal-effect TA systems [14,31]. On the other hand, many strains (both Hawaiian and non-Hawaiian) have none of the three TAs, suggesting dynamic intraspecific evolution of the TA systems.

Materials and methods

C. elegans strains

C. elegans strains were maintained at 20 °C on nematode growth medium (NGM) plates seeded with OP50 bacteria according to previous methods [32]. The XZ1516 strain was requested from the CaeNDR database [9]. Transgenesis was performed by injecting the recombinant DNA into the gonad of young adults, and transgenic animals were maintained by picking the transformants with fluorescent co-injection markers. For CRISPR/Cas9-mediated gene editing in C. elegans, the recombinant Cas9, sgRNA, and the repair template were injected together into the worm gonads, and the progeny were screened by PCR-based genotyping. Some strains were provided by the Caenorhabditis Genetics Center (CGC). All strains used in this study are listed in the S3 Table.

Alignment, variant calling, genome assembly, gene annotation, and visualization

In general, the alignment of the short-read sequencing results was done using STAR (v2.7.11b) and bwa mem (v0.7.19-r1273) with default parameter for splicing and non-splicing alignment, respectively. Deepvariant (v1.5.0) were used for variant calling. Lastz (v1.04.15) and mummer (v3.0.0) were used for large scaffolds pairwise alignment. Bedtools (v2.31.1), Conda (v24.11.3), Singularity (v3.8.0), and snakemake (v7.25.4) were used to coordinate computational tasks on high-performance cluster and to ensure reproducibility. The scaffold-level genomes of 14 C. elegans wild isolates were downloaded from NCBI [PRJNA692613], and ragtag (v2.1.0) was used to assemble the wild isolates genomes into chromosome level with the guide of N2 reference genome (WS285). Funannotate (v1.83) was used to de novo-annotate the chromosome-level genomes. The assembled genomes were uploaded to NCBI [PRJNA1477378]. CB4856 genome was downloaded from NCBI [GCA_963921145.1 from PRJEB26645]. Blastp (v2.16.0+) was used to compare the homology of proteome between wild isolates and N2. Exonerate (v2.80.0) was used to re-annotate the conserved or pseudogenized genes in wild isolates. Visualization of the genomic data is performed in R using ggplot2 (v3.5.2), ggtree (v3.12.0), and a self-built R package ggexon (https://github.com/DongyaoLiu/ggexon). Software used in this study are listed in S4 Table. All original code has been deposited at the github repository (https://github.com/DongyaoLiu/ToxinAntidote).

Chromosomal mapping of the TA in XZ1516

For chromosomal mapping, we used the transgenes zdIs5[mec-4p::GFP] I, muIs32[mec-7p::GFP] II, uIs31[mec-17p::GFP] III, uIs115[mec-17p::TagRFP] IV, uIs134[mec-17p::TagRFP] V, and uIs130[lad-2p::GFP] X as the chromosomal markers for N2 and counted the percentages of live and arrested animals carrying the fluorescent marker among the offspring of the N2/XZ1516 hybrid. At least three biological replicates were carried out, and more than 500 F2 progeny were examined for each marker.

Introgression and the mapping of the TA elements

To introgress the XZ1516-derived TA system into the N2 strain, we crossed N2 males with XZ1516 hermaphrodites and picked N2/XZ1516 hermaphrodites to cross them with N2 males again. We then repeated the cross for seven rounds and obtained the near isogenic line named CGZ1589. To make sure CGZ1589 carries the TA system, we crossed it with N2 and found rod-like arrested animals among the progeny of N2/CZ1589 hybrids. We then extracted genomic DNA from CGZ1589 using the Puregene tissue core Kit (Qiagen, cat# 1126829). Ten micrograms of the DNA was used for library construction and sequencing by BGI (Beijing Genome Institute, China) on the DNBSEQ PE150 platform. The sequencing depth is ~100×. Raw sequencing file of the introgressed strain is uploaded to NCBI Sequence Read Archive (SRA) under the accession number PRJNA1359096.

To generate high-quality genomic variants between XZ1516 and N2. We use ART (v2016-06-05) to simulate 200 bp pair-end reads from N2 and XZ1516 (with the 50× depth) and map the simulated reads to each other’s genome (we used the reference genome WS285 for N2 and assembled the XZ1516 genome from long-read sequencing results). We used deepvariant (v1.5.0) to identify N2 variants based on the XZ1516 genome and XZ1516 variants based on the N2 genome and then intersected the two lists of variants to identify the final high-quality variants. We then mapped the sequencing reads of the introgressed strain CGZ1589 to the N2 reference genome and counted the reads that support either the N2 variants or XZ1516 variants (at the high-quality variant sites with alternative alleles) across the genome. The read depth of different alleles in CGZ1589 were quantified using bam-readcount (v1.0.1). The region that contains most reads supporting the XZ1516 variants was identified as the TA-containing region (17–22 Mb on the right arm of chrV).

We then filtered the genes annotated in this region of the XZ1516 genome for gene size (genes coding proteins longer than 100 amino acids), expression levels (with supporting RNA-seq reads), and the level of homology with N2 genes (lower than 80% identity) and obtained a list of genes for RNAi screen. To include the possibility that the TA system may be located on the scaffolds that were not assembled into the chromosome-level XZ1516 genome, we also used Augustus (v3.5.0) to predict the genes located on any scaffolds aligned to N2 chrV and identified genes with the support of RNA-seq reads (PRJNA669810).

RNAi screen for the antidote gene

Feeding RNAi was carried out using a previously described protocol [33]. The cDNAs of the 46 candidates for the antidote gene were cloned from the cDNA library of XZ1516 and inserted between the two T7 promoters in the L4440 vector using Gibson Assembly (primers used for the cloning were listed in S1 Table). The resulted DNA constructs were transformed into E. coli HT115 strain. The bacteria containing the RNAi constructs were seeded onto NGM plates with 5 mM IPTG to induce the expression of dsRNAs. The next day, 30 bleach-synchronized embryos were placed onto the RNAi plates. The next generation were examined for the presence of rod-like arrested larvae.

Genotyping for the inheritance pattern of the sept-1/zina-1 locus

Live F2 progeny generated by various F1 hybrids were subjected to single-worm PCR. For the experiments that involved extrachromosomal arrays expressing the antidote, we only genotyped F2 animals that were alive and carried the array. At least three replicates were carried out, and more than 96 animals were genotyped for each cross. The genotyping primers were listed in S5 Table.

DNA constructs and expression reporters

We performed Gibson Assembly for cloning in this study using ClonExpress II One Step Cloning Kit (cat# C112-01) from Vazyme (Nanjing, China). To generate the transcriptional reporters, a 2-kb sept-1(XZ1516) promoter and a 2-kb sept-1(N2) promoter were cloned from the genomic DNA of XZ1516 and N2 strains, respectively, and then ligated upstream of TagRFP and a tbb-2 3′UTR in the pUC57 backbone. For the zina-1 rescue experiment, zina-1 fragment containing a 2-kb zina-1 promoter, the entire coding region, and a 1-kb zina-1 3′UTR was cloned from XZ1516 genomic DNA. We then swapped out the zina-1 promoter with a 2-kb promoter upstream of the zina-1(N2ψ), a 2-kb ges-1 promoter, or a 2-kb myo-2 promoter from the N2 genomic DNA. To test the detoxification ability of zina-1(N2*), which is the repaired zina-1 allele in N2, we cloned the zina-1 coding sequence from the cDNA library of animals carrying the zina-1(unk232) allele or substituted the exon 3 of the zina-1(N2ψ) cloned from N2 cDNA library with the exon3 and exon4 of zina-1 from XZ1516 cDNA library. This zina-1(N2*) fragment was then placed downstream of either zina-1 promoter or the zina-1(N2ψ) promoter. To make zina-1p::GFP transcriptional reporters, a 2-kb zina-1 promoter and a 1-kb zina-1 3′UTR were cloned from the XZ1516 genomic DNA and were ligated to the upstream and downstream of GFP coding sequences, respectively. To make zina-1 translational reporter, GFP coding sequence is inserted upstream of the zina-1 coding sequence in the zina-1 fragment containing the promoter, the coding region, and the 3′UTR cloned from the XZ1516 genomic DNA. All DNA constructs generated and used in this study are listed in S6 Table.

MosTI single-copy insertion

We used the previously described modular safe-harbor transgene insertion (MosTI) method for the insertion of single-copy transgenes [20]. Briefly, we cloned the genomic DNA of sept-1(XZ1516) and sept-1(N2) and ligated it to the downstream of the hsp-16.41 promoter and the upstream of the tbb-2 3′UTR on the pSEM246 backbone through Gibson Assembly. The resulted constructs were injected into the CFJ42 strain, which carries a landing site (kstSi42) on chromosome II and the unc-119(ed3) mutation. Successful integrants were selected based on normal locomotion and were confirmed through genotyping and sequencing. We obtained and tested multiple lines from each transgenesis. The results of the following lines were shown: unkSi32 and unkSi18 expressed sept-1(XZ1516) and sept-1(N2), respectively, from the heat-shock promoter, while unkSi42 and unkSi46 expressed 2xHA-tagged SEPT-1(XZ1516) and SEPT-1(N2), respectively, from the heat-shock promoter.

CRISPR/Cas9-mediated gene editing

Gene editing was conducted using our previously published protocol [34]. Cas9 cut sites were predicted using CHOPCHOP (https://chopchop.cbu.uib.no). Single-guide RNAs were prepared by in vitro transcription using the NEB sgRNA synthesis kit (E3322S) and were incubated with recombinant SpCas9 protein (NEB cat# M0646T) at 37 °C for 15 min. The RNP (2 μM Cas9 and 100 ng/μL of guide RNA in final concentration) was then mixed with a linearized muscle-expressing co-injection marker construct (CGZ#400, ttr-16p::GFP at 10 ng/μL), repair template (at 100 ng/μL if needed), and filler DNA (1 kb plus DNA ladder, Invitrogen cat#10787018). For insertion or substitution longer than 150 bp, we used a previously described PCR method to generate repair template with overhangs [35]. For edits shorter than 150 bp, single-stranded donor oligos were used as repair template. After the injection, transformants with GFP expression in the body wall muscle were picked to individual plates and genotyped by PCR and Sanger sequencing to find the correctly edited allele. In some cases, we also used a co-CRISPR protocol [36] to screen for the successfully edited animals with dpy-10(cn64) as the co-conversion marker. The sequences of the CRISPR/Cas9 target and repair templates used to generate the edited alleles were listed in S7 Table.

smFISH, antibody staining, and microscopy imaging

smFISH probes against the sept-1(XZ1516) coding region were designed using the Stellaris RNA FISH Probe Designer tool from Biosearch Technologies (Petaluma, CA) and synthesized with Quasar 670 dye. The sequence of the probes can be found in S8 Table. Dissected adult gonads and early embryos from various strains were fixed, stained with the FISH probe sets (125 nM as the final concentration) in the hybridization buffer (purchased from Biosearch Technologies), and then washed using the wash buffer based on a previous protocol [37]. For antibody staining, we used the Ruvkun protocol [38]. Early embryos were fixed in the fixation buffer and underwent three rounds of freeze-thaw cycles. Anti-HA mouse monoclonal antibody (TransGene, HT301-02) and anti-mouse secondary antibodies (Thermo-Fisher, cat# 31430) were used at 1:1,000 dilution; animals were incubated with the antibodies in the antibody buffer A (1× PBS, 1% BSA, 0.5% Triton X-100, 1 mM EDTA). Leica fluorescent microscopy (DMi8 with K5 monochrome camera) was used to image the larvae and adults. Embryos and dissected gonads were imaged on Confocal Laser Scanning Microscope (Carl Zeiss LSM 980).

RNA sequencing and mapping of A-to-I editing

Mixed-stage worms were collected from three 100 mm NGM plates. Two biological replicates were prepared for each strain. Total RNAs were extracted using TRIzol reagent (Thermo Fisher). One milligram of total RNA were used for beads-based mRNA capturing and library construction and were sequenced on DNBSEQ-T7 by BGI. 6G adaptor-trimmed reads were used for downstream analysis. All raw RNA-seq data were uploaded to NCBI SRA under the accession number PRJNA1359096. Mapping followed the protocol mentioned above. The A-to-I mutation were identified by bcftools (v1.21).

Phylogenetic tree and mapping TA systems in wild isolates

The phylogenetic tree for the wild isolates was calculated by iqtree(v1.5.5) using concatenated CDS of 4,736 single-copy gene defined by previous studies [26]. The CDS variations were extracted from vcf file and install to the reference transcripts using a modified script (https://github.com/DongyaoLiu/vcf2fasta). Genomic data of C. elegans wild isotypes and the corresponding hard-filtered vcf file were downloaded from CaeNDR (v20231213). Fastq files were extracted from the bam alignment file. We used two independent approaches to map peel-1/zeel-1, sup-35/pha-1, and sept-1/zina-1 in C. elegans wild isolates.

First, we extracted all reads mapped to each corresponding locus in the N2 reference genome (WS285) and unmapped reads using samtools (v1.16.1) from the bam files and performed local de novo assembly using SPAdes (v3.15.4). The resulting scaffolds were used to annotate each TA system using Exonerate (v2.2.0). If the re-annotation produced a hit with protein identity to the query ≥80% and annotated protein length ≥80% of the reference protein length, we considered the gene “present”. If the de novo assembly existed but no hit met the above threshold, we considered the gene “absent”. Thus, for sup-35, genotypes matching sup-35(DL238) or sup-35(XZ1516) were significantly diverged from sup-35(N2) and were considered sup-35(-). If nonsense or frameshift mutation were detected, we also considered the gene “absent”. If no assembly was available, we considered the case to be “N.D.” for “not determined”.

In parallel, we conducted conventional short-read mapping against the reference genome followed by variant calling using ANNOVAR. The gene was considered “present” if all CDS intervals for the gene had coverage_fraction_d10 = 1.0 (100% of CDS bases covered at ≥10× read depth) using samtools depth. For peel-1, zeel-1, sup-35, pha-1, and sept-1(N2), we used the N2 (WS285) CDS coordinates. For sept-1(XZ1516) and zina-1, we used XZ1516 genomic CDS coordinates. The gene was considered “absent” if any CDS interval failed the above criteria. If nonsense or frameshift mutation were detected after the BAM file passed the depth check, we considered the gene “absent”. We considered the case to be “N.D.” if no BAM file exists for the strain.

The results of the above two approaches were then combined. A gene was called “present” if either approach supports its presence and no nonsense or frameshift mutation were found. A gene was called “absent” if neither approach supports its presence. A gene was called “N.D.” if both approaches resulted in “N.D.” In addition, we visually examined the read depth coverage of the antidote genes when the toxin was present but the antidote was missing to make sure the results of the genotype calling is correct.

To visualize the genomic region harboring the sept-1/zina-1 system in other Caenorhabditis species, we selected nine Caenorhabditis species relative to C. elegans and analyzed their genomes, including C. briggsae (GCA_000004555.3), C. tropicalis (GCA_016735795.1), C. nigoni (GCA_002742825.1), C. latens (GCA_002742825.1), C. wallacei (GCA_963932035.1), C. brenneri (GCA_964036135.1), C. sp54 (GCA_965234135.1), C. innopinata (GCA_003052745.1), and C. bovis (GCA_902829315.1). The genomic sequences of rpl-2, calf-1, and dhcr-7 from these genomes and the genomes of the wild isolates were used to construct a phylogenetic tree.

Statistical analysis

All quantitative data were presented as mean ± SD. At least three biological replicates were performed. For categorical data (percentage of animals carrying the marker or being alive), we used Chi-squared test to detect the statistically significant deviation from the expected frequencies. The p values were corrected using Bonferroni correction for multiple comparisons in one experiment. To compare two curves, we used the non-parametric Kolmogorov–Smirnov (KS) test. Detailed statistical information can be found in the figure legends.

Supporting information

S1 Fig. sup-35/pha-1 is inactivated in XZ1516.

(A) A comparison of the zeel-1/peel-1 locus between XZ1516 and N2 shows good conservation of synteny (gray lines). (B) A comparison of the sup-35/pha-1 locus between XZ1516 and N2 shows several genomic rearrangement events. pha-1 is split into two short ORFs (pha-1#1 and pha-1#2) due to a deletion event in XZ1516. This split likely inactivated the pha-1 gene function. sup-35 is duplicated into sup-35#1, sup-35#2, and sup-35#3 due to duplication and inversion events but all three copies have shown significant sequence divergence from sup-35(N2), which likely leads to the loss of toxicity (see S8 Fig for details). sup-35 also shows similarity to Y48A6C.4, which is duplicated and split into three copies in XZ1516. (C) The sup-35(unk210) allele in N2 strain created in this study through CRISPR/Cas9-mediated gene editing. Premature stops were inserted into the first exon to inactivate the gene. (D) Cross schemes used to test the inheritance pattern of the chrV-linked novel TA in XZ1516. The black bars indicate the N2 chrV carrying a TagRFP-expressing fluorescent reporter (pink). The brown bars indicate the homologous XZ1516 chrV carrying a novel TA system. The results of the crosses indicate the presence of maternal deposit of the XZ1516-derived toxin. Among the alive progeny, we only scored the males, which are for sure the cross-progeny. (E) The result of the cross indicates the lack of paternal deposit of the XZ1516-derived toxin.

(TIF)

pbio.3003563.s001.tif (1.5MB, tif)
S2 Fig. Identification of the sept-1 and zina-1 as the toxin and antidote genes.

(A) XZ1516 animals treated with bacteria expressing dsRNA against zina-1 or carrying the empty RNAi vector L4440. Scale bars, 20 μm. (B) Gene structures of sept-1(XZ1516) long and short isoforms and the molecular lesions of the various alleles. (C) The count of reads that align to the region that is specific for the long isoform and the region shared by long and short isoforms. (D) The molecular lesion of the zina-1(unk221) null allele. Premature stops (red) were inserted into exon 3 using CRISPR/Cas9-mediated gene editing. The data underlying this Figure can be found in S1 Data.

(TIF)

pbio.3003563.s002.tif (1.5MB, tif)
S3 Fig. sept-1/zina-1 is a maternally inherited TA system.

(A) Cross schemes and the results of genotyping the F2 progeny. XZ1516 sept-1(unk192) mutants were used for “T-” and sept-1(unk192) zina-1(unk221) mutants were used as “TA-”. The introgressed strain CGZ1589 was used as N2 (TA). The toxin sept-1 was genotyped, and its presence in the genome of the F2 progeny was considered T+. (B) Two crosses that confirmed the maternal deposition of the SEPT-1(XZ1516) toxin by genotyping the offspring. In the left cross, 100% of the progeny were alive and ~50% carry the T+ genotype. In the right cross, only ~50% of the progeny were alive and they all carry the T+ genotype. Some images were created using Biorender. The data underlying this Figure can be found in S1 Data. Part of the Figure was created in BioRender. Zheng, C. (2026) https://BioRender.com/5fjhayv.

(TIF)

pbio.3003563.s003.tif (695.9KB, tif)
S4 Fig. Genomic editing of the sept-1/zina-1 locus.

(A) The zina-1(unk232) allele denotated as zina-1(N2*) was constructed by inserting 190-bp sequence into the exon 3 of zina-1(N2ψ). These sequences were taken from the exon 3 and exon 4 of zina-1(XZ1516). (B) The schematic presentation of the unkSi32[hsp16.41::sept-1(XZ1516)::tbb-2 3′UTR], unkSi18[hsp16.41::sept-1(N2)::tbb-2 3′UTR], unkSi42[hsp-16.41::sept-1(XZ1516)::2xHA::tbb-2_3UTR], and unkSi46[hsp-16.41::sept-1(N2)::2xHA::tbb-2_3UTR], which are single-copy insertions into the chrII: kstSi42 locus of the CFJ42 strain (N2 background) using the MosTI method. (C) Editing of the endogenous sept-1 locus in XZ1516 and N2. The coding sequence was replaced by the desired sequence using CRISPR/Cas9 gene editing. (D) The expression of sept-1 mRNA detected by RT-PCR in various animals. ama-1 served as an internal control.

(TIF)

pbio.3003563.s004.tif (1.3MB, tif)
S5 Fig. Induced expression of sept-1(XZ1516) generates stronger toxicity than sept-1(N2).

(A) RT-qPCR results showed the fold change of the induced expression of sept-1(XZ1516) and sept-1(N2) from the single-copy transgenes unkSi32 and unkSi18, respectively, at 2 hours after the 33 °C heat-shock of various duration. Fold change was calculated in comparison with the animals that did not undergo heat-shock. (B) Western blot results using anti-HA antibodies showed the expression of SEPT-1(XZ1516)::HA and SEPT-1(N2)::HA proteins from the unkSi42 and unkSi46 transgene, respectively, at 2 or 4 hours after a 30-min or 60-min heat-shock. Tubulin is used as a loading control. (C) Percentage of animals that survived 24 hours after the heat-shock at L1 or L4 stage. Three to five replicates were made for each condition with ~100 animals analyzed. Double asterisks indicate p < 0.01 in a Tukey’s test comparing the transgenic animals with the wild type or between the two transgenes (unkSi32 and unkSi18 were used). (D) L4-stage animals were heat-shocked at 33 °C for 60 min and then imaged at 24 hours after the heat-shock. Scale bars, 10 μm. The dorsoventral width (indicated by the lines) of the intestine was measured and normalized to the width of the worm body. Around 40 animals were analyzed. The data underlying this Figure can be found in S1 Data.

(TIF)

pbio.3003563.s005.tif (3.8MB, tif)
S6 Fig. Somatic expression of the sept-1(XZ1516) and sept-1(N2) genes.

Expression patterns of sept-1(XZ1516)p::TagRFP and sept-1(N2)p::TagRFP in the XZ1516 (A) and N2 backgrounds (B). The DNA constructs were injected into the two strains at the same concentrations, and the stable lines were imaged at different stages. Quantifications of the fluorescent intensity are shown in the bar graphs on the right. Expression of sept-1(XZ1516)p::TagRFP was stronger than sept-1(N2)p::TagRFP in both backgrounds. Scale bars, 20 μm. The data underlying this Figure can be found in S1 Data.

(TIF)

pbio.3003563.s006.tif (3.8MB, tif)
S7 Fig. Distribution of the three TA systems in C. elegans wild isolates.

A phylogenetic tree of 611 C. elegans wild isotypes constructed using optimal Bayesian models selected by ModelFinder based on the CDS of 4,736 single-copy genes. The presence and absence of the toxin and antidote genes were called using the criteria listed in the Materials and methods. Strains that were isolated from Hawaiian Islands are labeled in orange. The group each strain is assigned to is also shown. The tree file underlying this Figure can be found in S1 Data.

(TIF)

pbio.3003563.s007.tif (2.3MB, tif)
S8 Fig. Divergence of sup-35 among the C. elegans wild isolates.

(A) A comparison of the sup-35/pha-1 locus between DL238 and N2 shows the deletion of the pha-1 gene in DL238. An inversion event caused divergence of sup-35. However, unlike previously reported, sup-35 is not pseudogenized in DL238. An ORF can be constructed from the sup-35 gene in DL238. (B) Pairwise alignment of SUP-35(N2) and SUP-35(DL238). (C) A phylogenetic tree of rmd-1/2, sup-35, and Y48A6C.4 homologs from various C. elegans wild isolates and other nematodes. The location of sup-35#1~3 and Y48A6C.4#1~3 in XZ1516 genome can be found in S1 Fig.

(TIF)

pbio.3003563.s008.tif (2.4MB, tif)
S1 Table. Candidate genes for the antidote that were tested by RNAi.

Column A to E show the names and coordinates of the genes in XZ1516 genome. Column F shows the transcript name of the N2 gene aligned to the XZ1516 gene. Columns G to O show the alignment details with the XZ1516 gene as the query (e.g., Qstart and Qend) and the N2 gene as the target sequence (e.g., Sstart and Send). The percentage of identity for the alignment is shown in column O. Column P shows the RNA expression level of the candidate gene in XZ1516. Column S shows whether the RNAi of the gene induced the rod-like phenotype. Columns T and U list the primers used to amplify the target XZ1516 gene, and the amplified DNA fragments were inserted into L4440 for feeding RNAi.

(XLSX)

pbio.3003563.s009.xlsx (15.9KB, xlsx)
S2 Table. Distribution of the three TA systems in C. elegans wild isolates.

Detailed strain information for Figs 6A and S7. The number of strains and the number of Hawaiian strains in the group were shown. Groups 1–14 are Hawaiian groups because ≥ 50% of the strains are Hawaiian strains. Groups 15–24 are assigned as non-Hawaiian groups. The number of minority strains (i.e., non-Hawaiian strains in a Hawaiian group or Hawaiian strains in a non-Hawaiian group) is shown in the “Minority” column. The calling of the genotypes is described in Materials and methods. “N.D.” means the genotypes of the TA systems are unknown.

(XLSX)

pbio.3003563.s010.xlsx (14.2KB, xlsx)
S3 Table. A list of strains used in this study.

(XLSX)

pbio.3003563.s011.xlsx (11.4KB, xlsx)
S4 Table. A list of software used in this study.

(XLSX)

pbio.3003563.s012.xlsx (12.6KB, xlsx)
S5 Table. A list of primers used in this study.

(XLSX)

pbio.3003563.s013.xlsx (11.6KB, xlsx)
S6 Table. A list of DNA constructs used in this study.

(XLSX)

pbio.3003563.s014.xlsx (45KB, xlsx)
S7 Table. Details of the CRISPR alleles generated in this study.

(XLSX)

pbio.3003563.s015.xlsx (14KB, xlsx)
S8 Table. The sequence of the smFISH probes against sept-1.

(XLSX)

pbio.3003563.s016.xlsx (10.5KB, xlsx)
S1 Data. Numeric data underlying all main and supporting figures.

(XLSX)

pbio.3003563.s017.xlsx (7.6MB, xlsx)
S1 Raw Images. Original gel and blot images for S4D and S5B Figs.

(PDF)

pbio.3003563.s018.pdf (592KB, pdf)

Acknowledgments

We thank Miss Yanjun Gao and Mr Zifan Zhang for technical assistance in genotyping some animals. We thank CaeNDR for sharing C. elegans wild isolate strains and their genomic data. Some strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs (P40 OD010440). Computational works were performed using research computing facilities offered by Information Technology Services at the University of Hong Kong.

Abbreviations

NILs

near-isogenic lines

smFISH

single-molecule fluorescent in situ hybridization

SRA

Sequence Read Archive

TA

toxin-antidote

Data Availability

Genomic DNA sequencing data for the introgressed strain CGZ1589 and RNA sequencing data for XZ1516, CGZ1698, and CGZ2735 were uploaded to NCBI Sequence Read Archive (SRA) under the accession number PRJNA1359096. The reassembled chromosome-level genomes of the C. elegans wild isolates were uploaded to NCBI under the accession number PRJNA1477378. All individual numerical values underlying the figures are provided in the Supporting information file S1 Data. Original gel and blot images can be found in S1 Raw Images. All analysis scripts used in this study are publicly available at Zenodo (https://doi.org/10.5281/zenodo.21353375).

Funding Statement

This work is supported by the Research Grants Council of Hong Kong (https://www.ugc.edu.hk/eng/rgc/) through the grants GRF 17107325, GRF 17113324, and GRF 17105523 to C.Z. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Werren JH, Nur U, Wu CI. Selfish genetic elements. Trends Ecol Evol. 1988;3(11):297–302. doi: 10.1016/0169-5347(88)90105-X [DOI] [PubMed] [Google Scholar]
  • 2.Burga A, Ben-David E, Kruglyak L. Toxin-antidote elements across the tree of life. Annu Rev Genet. 2020;54:387–415. doi: 10.1146/annurev-genet-112618-043659 [DOI] [PubMed] [Google Scholar]
  • 3.Yamaguchi Y, Park J-H, Inouye M. Toxin-antitoxin systems in bacteria and archaea. Annu Rev Genet. 2011;45:61–79. doi: 10.1146/annurev-genet-110410-132412 [DOI] [PubMed] [Google Scholar]
  • 4.Ogura T, Hiraga S. Mini-F plasmid genes that couple host cell division to plasmid proliferation. Proc Natl Acad Sci U S A. 1983;80(15):4784–8. doi: 10.1073/pnas.80.15.4784 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Page R, Peti W. Toxin-antitoxin systems in bacterial growth arrest and persistence. Nat Chem Biol. 2016;12(4):208–14. doi: 10.1038/nchembio.2044 [DOI] [PubMed] [Google Scholar]
  • 6.Lai EC, Vogan AA. Proliferation and dissemination of killer meiotic drive loci. Curr Opin Genet Dev. 2023;82:102100. doi: 10.1016/j.gde.2023.102100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Félix M-A, Braendle C. The natural history of Caenorhabditis elegans. Curr Biol. 2010;20(22):R965-9. doi: 10.1016/j.cub.2010.09.050 [DOI] [PubMed] [Google Scholar]
  • 8.Crombie TA, Zdraljevic S, Cook DE, Tanny RE, Brady SC, Wang Y, et al. Deep sampling of Hawaiian Caenorhabditis elegans reveals high genetic diversity and admixture with global populations. Elife. 2019;8:e50465. doi: 10.7554/eLife.50465 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Crombie TA, McKeown R, Moya ND, Evans KS, Widmayer SJ, LaGrassa V, et al. CaeNDR, the Caenorhabditis natural diversity resource. Nucleic Acids Res. 2024;52(D1):D850–8. doi: 10.1093/nar/gkad887 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Seidel HS, Rockman MV, Kruglyak L. Widespread genetic incompatibility in C. elegans maintained by balancing selection. Science. 2008;319(5863):589–94. doi: 10.1126/science.1151107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Seidel HS, Ailion M, Li J, van Oudenaarden A, Rockman MV, Kruglyak L. A novel sperm-delivered toxin causes late-stage embryo lethality and transmission ratio distortion in C. elegans. PLoS Biol. 2011;9(7):e1001115. doi: 10.1371/journal.pbio.1001115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ben-David E, Burga A, Kruglyak L. A maternal-effect selfish genetic element in Caenorhabditis elegans. Science. 2017;356(6342):1051–5. doi: 10.1126/science.aan0621 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Caro L, Wei AD, Thomas CA, Posch G, Uremis A, Franzi MC, et al. An animal toxin-antidote system kills cells by creating a novel cation channel. PLoS Biol. 2025;23(5):e3003182. doi: 10.1371/journal.pbio.3003182 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ben-David E, Pliota P, Widen SA, Koreshova A, Lemus-Vergara T, Verpukhovskiy P, et al. Ubiquitous selfish toxin-antidote elements in Caenorhabditis species. Curr Biol. 2021;31(5):990-1001.e5. doi: 10.1016/j.cub.2020.12.013 [DOI] [PubMed] [Google Scholar]
  • 15.Widen SA, Bes IC, Koreshova A, Pliota P, Krogull D, Burga A. Virus-like transposons cross the species barrier and drive the evolution of genetic incompatibilities. Science. 2023;380(6652):eade0705. doi: 10.1126/science.ade0705 [DOI] [PubMed] [Google Scholar]
  • 16.Pliota P, Marvanova H, Koreshova A, Kaufman Y, Tikanova P, Krogull D, et al. Selfish conflict underlies RNA-mediated parent-of-origin effects. Nature. 2024;628(8006):122–9. doi: 10.1038/s41586-024-07155-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Palmer JM, Stajich J. Funannotate v1.8.1: eukaryotic genome annotation (v1.8). Zenodo. 2020. doi: 10.5281/zenodo.1134477 [DOI] [Google Scholar]
  • 18.Soukenik M, Diehl A, Leidert M, Sievert V, Büssow K, Leitner D, et al. The SEP domain of p47 acts as a reversible competitive inhibitor of cathepsin L. FEBS Lett. 2004;576(3):358–62. doi: 10.1016/j.febslet.2004.09.037 [DOI] [PubMed] [Google Scholar]
  • 19.Zdraljevic S, Walter-McNeill L, Bruni GN, Bloom JS, Leighton DHW, Collins JB. Divergent C. elegans toxin alleles are suppressed by distinct mechanisms. bioRxiv. 2024. doi: 10.1101/2024.04.26.591160 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.El Mouridi S, Alkhaldi F, Frøkjær-Jensen C. Modular safe-harbor transgene insertion for targeted single-copy and extrachromosomal array integration in Caenorhabditis elegans. G3 (Bethesda). 2022;12(9):jkac184. doi: 10.1093/g3journal/jkac184 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Batista PJ, Ruby JG, Claycomb JM, Chiang R, Fahlgren N, Kasschau KD, et al. PRG-1 and 21U-RNAs interact to form the piRNA complex required for fertility in C. elegans. Mol Cell. 2008;31(1):67–78. doi: 10.1016/j.molcel.2008.06.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Goldstein B, Agranat-Tamir L, Light D, Ben-Naim Zgayer O, Fishman A, Lamm AT. A-to-I RNA editing promotes developmental stage-specific gene and lncRNA expression. Genome Res. 2017;27(3):462–70. doi: 10.1101/gr.211169.116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ganem NS, Ben-Asher N, Manning AC, Deffit SN, Washburn MC, Wheeler EC, et al. Disruption in A-to-I Editing Levels Affects C. elegans Development More Than a Complete Lack of Editing. Cell Rep. 2019;27(4):1244–53 e4. doi: 10.1016/j.celrep.2019.03.095 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Leyva-Díaz E, Stefanakis N, Carrera I, Glenwinkel L, Wang G, Driscoll M, et al. Silencing of repetitive DNA is controlled by a member of an unusual Caenorhabditis elegans gene family. Genetics. 2017;207(2):529–45. doi: 10.1534/genetics.117.300134 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Van Melderen L, Bernard P, Couturier M. Lon-dependent proteolysis of CcdA is the key control for activation of CcdB in plasmid-free segregant bacteria. Mol Microbiol. 1994;11(6):1151–7. doi: 10.1111/j.1365-2958.1994.tb00391.x [DOI] [PubMed] [Google Scholar]
  • 26.Ma F, Lau CY, Zheng C. Young duplicate genes show developmental stage- and cell type-specific expression and function in Caenorhabditis elegans. Cell Genom. 2024;4(1):100467. doi: 10.1016/j.xgen.2023.100467 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Ma F, Lau CY, Zheng C. Large genetic diversity and strong positive selection in F-box and GPCR genes among the wild isolates of Caenorhabditis elegans. Genome Biol Evol. 2021;13(5):evab048. doi: 10.1093/gbe/evab048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Gallie DR, Lewis NJ, Marzluff WF. The histone 3’-terminal stem-loop is necessary for translation in Chinese hamster ovary cells. Nucleic Acids Res. 1996;24(10):1954–62. doi: 10.1093/nar/24.10.1954 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Rocheleau CE, Howard RM, Goldman AP, Volk ML, Girard LJ, Sundaram MV. A lin-45 raf enhancer screen identifies eor-1, eor-2 and unusual alleles of Ras pathway genes in Caenorhabditis elegans. Genetics. 2002;161(1):121–31. doi: 10.1093/genetics/161.1.121 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Cassandri M, Smirnov A, Novelli F, Pitolli C, Agostini M, Malewicz M, et al. Zinc-finger proteins in health and disease. Cell Death Discov. 2017;3:17071. doi: 10.1038/cddiscovery.2017.71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Noble LM, Yuen J, Stevens L, Moya N, Persaud R, Moscatelli M, et al. Selfing is the safest sex for Caenorhabditis tropicalis. Elife. 2021;10:e62587. doi: 10.7554/eLife.62587 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77(1):71–94. doi: 10.1093/genetics/77.1.71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Conte D Jr, MacNeil LT, Walhout AJM, Mello CC. RNA interference in Caenorhabditis elegans. Curr Protoc Mol Biol. 2015;109:26.3.1-26.3.30. doi: 10.1002/0471142727.mb2603s109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lu Y-M, Yan S, Ti S-C, Zheng C. Editing of endogenous tubulins reveals varying effects of tubulin posttranslational modifications on axonal growth and regeneration. Elife. 2024;13:RP94583. doi: 10.7554/eLife.94583 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Dokshin GA, Ghanta KS, Piscopo KM, Mello CC. Robust genome editing with short single-stranded and long, partially single-stranded DNA donors in Caenorhabditis elegans. Genetics. 2018;210(3):781–7. doi: 10.1534/genetics.118.301532 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kim H, Ishidate T, Ghanta KS, Seth M, Conte D Jr, Shirayama M, et al. A co-CRISPR strategy for efficient genome editing in Caenorhabditis elegans. Genetics. 2014;197(4):1069–80. doi: 10.1534/genetics.114.166389 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Topalidou I, van Oudenaarden A, Chalfie M. Caenorhabditis elegans aristaless/Arx gene alr-1 restricts variable gene expression. Proc Natl Acad Sci U S A. 2011;108(10):4063–8. doi: 10.1073/pnas.1101329108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Finney M, Ruvkun G. The unc-86 gene product couples cell lineage and cell identity in C. elegans. Cell. 1990;63(5):895–905. doi: 10.1016/0092-8674(90)90493-x [DOI] [PubMed] [Google Scholar]
  • 39.Kalyaanamoorthy S, Minh BQ, Wong TKF, von Haeseler A, Jermiin LS. ModelFinder: fast model selection for accurate phylogenetic estimates. Nat Methods. 2017;14(6):587–9. doi: 10.1038/nmeth.4285 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Roland G Roberts

26 Nov 2025

Dear Dr Zheng,

Thank you for submitting your manuscript entitled "sept-1/zina-1 is an Ancient Toxin-Antidote System in Caenorhabditis elegans" for consideration as a Research Article by PLOS Biology.

Your manuscript has now been evaluated by the PLOS Biology editorial staff, as well as by an academic editor with relevant expertise, and I'm writing to let you know that we would like to send your submission out for external peer review.

IMPORTANT: According to our scooping policy, we will explicitly ask the reviewers to ignore the recent related eLife publication from the Kruglyak lab when assessing novelty.

However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire.

Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. After your manuscript has passed the checks it will be sent out for review. To provide the metadata for your submission, please Login to Editorial Manager (https://www.editorialmanager.com/pbiology) within two working days, i.e. by Nov 28 2025 11:59PM.

If your manuscript has been previously peer-reviewed at another journal, PLOS Biology is willing to work with those reviews in order to avoid re-starting the process. Submission of the previous reviews is entirely optional and our ability to use them effectively will depend on the willingness of the previous journal to confirm the content of the reports and share the reviewer identities. Please note that we reserve the right to invite additional reviewers if we consider that additional/independent reviewers are needed, although we aim to avoid this as far as possible. In our experience, working with previous reviews does save time.

If you would like us to consider previous reviewer reports, please edit your cover letter to let us know and include the name of the journal where the work was previously considered and the manuscript ID it was given. In addition, please upload a response to the reviews as a 'Prior Peer Review' file type, which should include the reports in full and a point-by-point reply detailing how you have or plan to address the reviewers' concerns.

During the process of completing your manuscript submission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit http://journals.plos.org/plosbiology/s/preprints for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF.

Feel free to email us at plosbiology@plos.org if you have any queries relating to your submission.

Kind regards,

Roli Roberts

Roland Roberts, PhD

Senior Editor

PLOS Biology

rroberts@plos.org

Decision Letter 1

Roland G Roberts

4 Feb 2026

Dear Dr Zheng,

Thank you for your patience while your manuscript "sept-1/zina-1 is an Ancient Toxin-Antidote System in Caenorhabditis elegans" was peer-reviewed at PLOS Biology. It has now been evaluated by the PLOS Biology editors, an Academic Editor with relevant expertise, and by three independent reviewers. Please accept my apologies for the delay incurred over the holiday period.

You'll see that reviewer #1 is positive but makes some suggestions about gene nomenclature, wants some clarification around the claim that SEPT-1(N2) has lost toxicity, more detail around the transgenesis methods, questions some aspects of Fig 6, and suggests removal of Fig 7. Reviewer #2 is also positive, and sees this as complementary to the Zdraljevic et al study; however, s/he says that you need to measure expression levels of the SEPT-1 and SEPT-2 transgenes in order to support their stronger claims, complains about poor reporting of sample sizes and genetic cross directions, and raises a similar point to rev #1 about gene nomenclature. Reviewer #3 is again positive, but raises related issues about transgene expression, finds Fig 7 unconvincing (like rev #1), wants significantly more detail in the Methods, and has a list of presentational and textual requests.

IMPORTANT: I discussed these comments with the Academic Editor, who said, "I think that the methodological and reporting points made are quite significant and its important that the authors recognise the importance of addressing these thoroughly. Additionally, the 'selective sweep' section of the paper is very weak and should be removed as suggested by the reviewers."

In light of the reviews, which you will find at the end of this email, we would like to invite you to revise the work to thoroughly address the reviewers' reports.

Given the extent of revision needed, we cannot make a decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is likely to be sent for further evaluation by all or a subset of the reviewers.

In addition to these revisions, you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests shortly.

We expect to receive your revised manuscript within 3 months. Please email us (plosbiology@plos.org) if you have any questions or concerns, or would like to request an extension.

At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not intend to submit a revision so that we may withdraw it.

**IMPORTANT - SUBMITTING YOUR REVISION**

Your revisions should address the specific points made by each reviewer. Please submit the following files along with your revised manuscript:

1. A 'Response to Reviewers' file - this should detail your responses to the editorial requests, present a point-by-point response to all of the reviewers' comments, and indicate the changes made to the manuscript.

*NOTE: In your point-by-point response to the reviewers, please provide the full context of each review. Do not selectively quote paragraphs or sentences to reply to. The entire set of reviewer comments should be present in full and each specific point should be responded to individually, point by point.

You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response.

2. In addition to a clean copy of the manuscript, please also upload a 'track-changes' version of your manuscript that specifies the edits made. This should be uploaded as a "Revised Article with Changes Highlighted" file type.

*Re-submission Checklist*

When you are ready to resubmit your revised manuscript, please refer to this re-submission checklist: https://plos.io/Biology_Checklist

To submit a revised version of your manuscript, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' where you will find your submission record.

Please make sure to read the following important policies and guidelines while preparing your revision:

*Published Peer Review*

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

*PLOS Data Policy*

Please note that as a condition of publication PLOS' data policy (http://journals.plos.org/plosbiology/s/data-availability) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5

*Blot and Gel Data Policy*

We require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements

*Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Roli Roberts

Roland Roberts, PhD

Senior Editor

PLOS Biology

rroberts@plos.org

------------------------------------

REVIEWERS' COMMENTS:

Reviewer #1:

In the manuscript by Liu and Zheng, the authors identified and studied a toxin-antidote (TA) system in C. elegans, which they called sept-1/zina-1. A recent paper (Zdraljevic et al., elife, 2025 preprint v1) has reported the same TA system with a different name mll-1/smll-1 in the wild C. elegans strain XZ1516 and explained the suppression of a divergent version of mll-1 in the reference C. elegans strain N2 by small RNA silencing. Although Liu and Zheng also identified the TA system in the strain XZ1516, they used different methods and concluded that the divergent version of sept-1 in the strain N2, which they named sept-2, is derived and no longer toxic. Overall, the authors provide solid evidence for most conclusions in the manuscript. The authors should however address the criticisms below.

Major criticisms:

1.Naming of the genes:

a.Because Zdraljevic et al. have identified the same system and reported them first, it would be less confusing for readers and the community if the same names were used in this work. In any case, C. elegans gene names should be registered with genenames@wormbase.org

b.The N2 version of sept-1 (if this gene were called 'sept-1') should be referred to in the format as sept-1(N2) or sept-1 in N2. It is not appropriate to call it sept-2, because sept-1(XZ1516) and sept-1(N2) are divergent alleles of the same gene with no ambiguity relative to their relationship as they are syntenic and single-copy.

2.About the conclusion that SEPT-1(N2) has lost most of its toxicity:

a.The direct evidence is Figure 3D, based on the comparison of a single-copy heat-shock construct. The reviewer could not find the number of assayed animals and whether the data derive from one or several lines. Please also verify that no artificial mutations were introduced into the transgene that may interfere.

b.The reviewer cannot see a single-copy experiment that compares the two alleles under their own or the same sept-1(XZ1516) cis-regulatory region, for example one such as in panel E compared in parallel to XZ1516, with clear indication of number of animals. (Recoding to remove potential piRNA sites in panel G may also affect the level of expression so the authors cannot use this experiment to conclude that SEPT-1(N2) has lost toxicity.)

c.Interpretation: To the reviewer, this study does not necessarily "contradict" (line 216) that of Zdraljevic et al but instead they may reflect quantitative, context-dependent effects. In Zdraljevic et al., the experimental approach appears to drive substantially higher expression levels than the method used here, which could account for the stronger or qualitatively different phenotypes observed. In the Figure 3D in this study, long exposure to heat-shock did cause larval arrest.

d.Wording about the "small RNA-mediated suppression" is unclear. Maybe adding "mechanism" at the end would help. For the reader to understand the context, it would be good that you expand a little more about what is known (presence of piRNAs, small RNA sequence data, etc.). Other small RNA pathways than those started by primary piRNAs may be active here. Are the small RNAs actually removed when the gene is recoded?

e.Is sept-1(N2) expressed at a detectable level (using available expression data from the Andersen laboratory, in comparison with XZ1516)? Is its expression altered by recoding? line 221 refers to Fig. 3F but this is just the design of the recoding not the proof that sept-2 is expressed as suggested by the sentence.

3. About sept-1 expression pattern: Transgenesis methods for the expression reporters are not described. Are they multicopy reporter or single-copy insertions like the rescue constructs? From the strain list, they seem to be multicopy. The expression site in somatic cells differs from that reported in Zdraljevic et al. (germline) using smFISH. Maybe this is due to the technique involved as transgenes are more likely silenced in the germline, especially if multicopy. This does not seem to be a good choice and the caveat should at least be stated clearly. It is likely that the expression of single-copy transgenes is too weak to see it and that smFISH is indeed more appropriate.

4. The distribution of TAs can be summarized using a tree representation as in Figure 6. However, C. elegans populations do recombine so the tree representation may not reflect the history of the genomic region involved. The grouping in Hawaiian 1 and 2 seems artificial. It is thus not appropriate to draw evolutionary conclusions about which allele is ancestral, just based on this. In addition:

a.Strain names cannot be seen in Figure 6. Please provide a supplemental file including the detailed information about the three TA existence status for the 611 C. elegans strains. Please also include notes about whether the version likely lost function, as in sept-1(N2) and sup-35(XZ1516).

b.In Figure 6, how similar or divergent the sequence needs to be to the reference to be identified as "present" or "absent"? Maybe using gradient color? Please also include this information in the above supplemental file.

c.Revise accordingly the two last paragraphs of the Discussion. Regarding the last paragraph, please note that some co-occurring TAs have been found in C. tropicalis (Noble et al. 2021, Ben-David et al. 2021).

5. The reviewer strongly suggests completely removing the last section of the Results and Figure 7. They cannot see evidence for a selective sweep marked by a lower pi diversity of the sept-1 allele. Fig. 7 rather show an increase in pi in this region and in any case the region is too large to conclude.

6. The reviewer does not understand the Bayes Empirical Bayes analysis concluding to positive selection on the antidote gene in Fig. 2: in the context of these C. elegans polymorphisms, can you explain and provide methods? None is referenced.

Minor criticisms:

1.Provide the sequences of the constructs and CRISPR alleles.

2.Table S4 "Cloning primers" is empty.

3.In all figures or legends, please indicate the number of animals examined.

4.Figure 1H, y axis label should read "Percentage of animals" (idem in other figures)

5.Figure 1I, the y-axis is confusing (no legend explaining the solid line versus the dots).

6.Figure 2C and line 165: explain what you mean by identity (protein sequence?) and similarity (DNA level?). Typo on "similairy" on figure.

7.Figure 4, the stem-loop part is perhaps interesting but a little distracting from the main topic of the paper.

8.Line 90: remove the last sentence of the Introduction that is highly speculative.

9.line 221: rephrase. This is the rationale but you do not show that the expression is increased. (as mentioned above)

10.Line 314: remove "ecological".

11.Line 383: add the allele/strain names for SEPT-1

12.Line 388: what is the evidence for stabilization in the germline?

13.Line 496: provide the source of the genomes. Idem for RNAseq data when relevant.

14.Typos/grammar in page 14, lines 461 (past tense), 464 (remove "do");

p. 15 lines 484 (to cross them), 485 (isogenic), 486 (crossed), 496 (each other's genome)

p. 16 lines 526 (involved), 538 typo

p. 18 lines 573 "and the"? "plates", 575 (Leica), 580 (Mixed), 581 (strain), 593 (extracted).

p.19 line 608 (resolutions).

Reviewer #2:

In this manuscript, Liu et al. present the genetic mapping and characterization of a novel toxin-antidote (TA) element in C. elegans. This new maternal-effect TA, sept-1/zina-1, was identified in the highly divergent isolate XZ1516 and causes larval lethality in F2 non-carrier individuals. The authors did an excellent job mapping both the toxin- and antidote-encoding genes, and the results are very clean. Although a related element was previously described by the Kruglyak lab (Zdraljevic et al., 2025), the strain collection and overall mapping strategy were different, so the two studies are complementary and together strengthen the conclusions.

Liu et al. also make several additional observations. In particular, they show that expression of the antidote in the embryonic gut is sufficient for rescue, suggesting that the toxin acts in this tissue. They report interesting A-to-I editing of the toxin mRNA, although this does not appear to affect toxic activity. Finally, and most importantly, the authors disagree with Zdraljevic et al. regarding the toxicity and regulation of the highly divergent toxin (sept-2) present in the N2 reference strain.

Overall, the manuscript is clearly written and well organized, but I have several technical comments and some concerns regarding data presentation.

Specific points

1. Toxicity of the N2 toxin (sept-2 / B0250.8 / mll-1)

The main disagreement between this study and Zdraljevic et al. (2025) concerns the intrinsic toxicity of the N2 toxin, B0250.8 (called sept-2 here and mll-1 in Zdraljevic et al.).

Zdraljevic et al. concluded that N2 mll-1 is toxic because overexpression using a tetracycline-inducible system caused abnormal phenotypes in N2, DL238, and XZ1516 backgrounds, similar to those observed upon overexpression of the XZ1516 toxin (sept-1). To explain why toxicity is not normally manifested in the N2 background (despite the absence of a functional antidote), they proposed that N2 mll-1 is repressed by a small-RNA pathway involving secondary 22G-RNAs. Although the evidence for this model is not particularly strong, it is plausible, and it is consistent with previous reports showing that B0250.8 is among the most strongly up-regulated genes in mut-16 mutants.

In contrast, Liu et al. conclude that sept-2 is not capable of poisoning N2. They generated single-copy transgenic lines expressing either sept-1 or sept-2 from a heat-shock promoter and found that a 20-30 min heat shock killed most larvae carrying the sept-1 transgene, whereas sept-2 transgenic larvae were largely unaffected. Interestingly, prolonged heat shock (50 min) of sept-2 transgenics did cause lethality, which the authors interpret as evidence for "weaker toxicity".

These experiments, however, lack a critical control: direct measurement of SEPT-1 and SEPT-2 expression levels. Although MosTI-based integration is reliable for transgene insertion, it does not guarantee expression. The piRNA (21U-RNA) pathway can recognize transgenes and induce somatic and/or germline silencing. Moreover, given prior evidence that sept-2 is regulated by small RNAs, the endogenous pre-existing 22G-RNAs may also target the transgene, resulting in reduced expression. The apparent "weaker toxicity" could therefore simply reflect lower protein levels, and dosage effects are well known in TA systems.

If strong conclusions are to be drawn about the relative toxicity of SEPT-1 and SEPT-2, transgene expression must be directly assessed, for example by western blotting or immunofluorescence. A straightforward approach would be to introduce an N- or C-terminal FLAG (or similar) tag. Importantly, the activity of the tagged protein should first be validated by tagging SEPT-1 at its endogenous locus and confirming that toxicity is retained.

The authors also attempted to test sept-2 toxicity by replacing the sept-1 coding sequence at the endogenous XZ1516 locus with sept-2, using a recoded version to remove putative piRNA target sites. They state that "this recoding likely removed the potential piRNA binding sites in the coding sequence and allowed sept-2 to be expressed, and its toxicity be revealed." However, the manuscript does not clearly describe how this recoding was performed. Which tool was used? Were known piRNA sequences explicitly avoided, or were synonymous mutations introduced more randomly under the assumption that this would disrupt piRNA targeting? This is not clear from the Methods or figure legends.

Furthermore, even if recoding successfully avoided N2 piRNAs (no evidence is provided), piRNA repertoires differ between strains. Because piRNAs are genomically encoded and polymorphic, one cannot assume that a sept-2 sequence recoded based on N2 information will escape silencing in XZ1516. Since the authors conclude that sept-2 is not toxic, it is essential to demonstrate that the recoded gene is in fact expressed in the relevant tissues and stages.

2. Reporting of sample sizes and raw counts

Throughout the manuscript, I could not find clear information on N (number of independent experiments) and n (sample size per experiment) for most crosses and assays. Only percentages and p-values are typically reported. For reproducibility and transparency, I strongly encourage the authors to provide raw counts and full experimental details in the supplementary material and to reference sample sizes consistently in the main text and figure legends.

3. Direction of genetic crosses

Related to the previous point, the direction of many crosses is not specified. For example, in the initial result showing that ~40% of progeny from N2 × XZ1516 crosses display developmental defects, it is unclear whether XZ1516 hermaphrodites were crossed to N2 males or vice versa. Previous work (Pliota et al., 2024) has demonstrated that cross direction can critically affect TA activity in C. tropicalis; for instance, the maternal-effect slow-1/grow-1 system is only active when paternally inherited. For completeness and clarity, the direction of all crosses should be explicitly stated.

4. Identity and nomenclature of sept-1/zina-1 and mll-1/smll-1

At line 183, the authors state that the TA system described by Zdraljevic et al. is "likely the same as" sept-1/zina-1. There is, in fact, no ambiguity here: sept-1/zina-1 and mll-1/smll-1 correspond to the same locus and should be described as such.

In addition, I am not sure whether it is advisable to introduce new gene names (sept-1 and zina-1) in this context. In general, redundancy in gene nomenclature should be avoided whenever possible. Here, it is clear that the genes in question are identical to those previously described, and there seems to be no strong justification for maintaining two parallel naming schemes for the same TA system.

5. Mutual exclusivity of maternal TA systems

At line 417, the authors note that sept-1/zina-1 and sup-35/pha-1 are almost mutually exclusive, and suggest that this may reflect an energetic cost of maintaining two maternal TA systems. While the observation is interesting, previous work (Ben-David et al., Current Biology, 2021) showed that some C. tropicalis isolates (e.g., NIC203 and EG6180) carry two or even three active maternal-effect TAs, arguing against a strong general fitness cost of harboring multiple such systems. The apparent anti-correlation between sup-35/pha-1 and sept-1/zina-1 could therefore be coincidental. I would recommend either toning down this interpretation or, if the authors wish to emphasize it, directly testing the hypothesis by comparing the fitness of NILs carrying both TA systems with appropriate single-TA and double-knockout controls. Overall, claims about the relative age of the TAs should be toned down. The evidence is rather indirect.

6. SEP-domain

The authors named the toxin after its SEP-domain. I may have missed this, but there was no reference or explanation to what is known about this protein domain.

Reviewer #3:

[identify themselves as Daniel Park and Michael Ailion]

Toxin-antidotes (TAs) promote their own inheritance with little or no benefit to their host. TAs are widespread in prokaryotes, and they are now being found and characterized in eukaryotes. In this manuscript, the authors identify and characterize a new TA in a divergent Hawaiian strain of C. elegans, the third one found in this species. Strong genetic evidence is provided that the sept-1 toxin is maternally transmitted and causes larval arrest in the absence of its zygotically expressed antidote zina-1. Additional convincing experiments show that in the standard lab strain N2, the toxin gene has been retained but has lost toxicity due to sequence divergence, while the antidote has become pseudogenized. The manuscript concludes with an interesting phylogenetic analysis of the three known TAs in C. elegans, suggesting that the two known maternal effect TAs do not coexist in the same strain. Overall, the work is performed well and most of the conclusions are supported by the data. This is an interesting and solid new addition to the growing literature in the field of eukaryotic TAs.

Considerations

1. The larval arrest phenotype is described as "rod-like." This designation has previously been used to describe the larval arrest phenotype of mutants in the Ras pathway, due to malfunction of the excretory duct system and defects in osmoregulation. But it is not clear whether the larval arrest phenotype due to sept-1 toxicity is this same rod-like phenotype. First, the arrested larvae shown in this manuscript are not straight rods, but have a curved posture (e.g. Fig 5C&D and Fig S2A). Second, given that the toxins causes defects in the morphology of the intestine and the zina-1 antidote acts in the intestine, it is unclear whether this is equivalent to the previously described rod-like arrest of mutants that affect the excretory system. This issue warrants further discussion, and without further evidence, it would be prudent to use a term other than "rod-like" for the arrest phenotype.

2. It is unclear if sept-1 is only capable of toxicity at the L1 larval stage. What happens if animals carrying hs::sept-1 are heat-shocked as older animals? Is there any evidence for toxicity in tissues other than the intestine?

3. Lines 279-284 and Figure S5. Based on images of sept-1p and sept-2p transcriptional reporters, it is concluded that sept-1 is expressed at a higher level. This is not convincing and the conclusion should be toned down. First, there are only single images with no quantification. Second, these strains carry extrachromosomal arrays, which are overexpressed and may be at different copy levels. There is often a lot of variability between independent arrays of the same construct, so it is not meaningful to quantitatively compare individual arrays of two different constructs. It is unclear how many arrays of each construct were generated, but quantitative analysis of a large number of arrays of each construct would be necessary to even begin to be meaningful. Single-copy insertions at the same chromosomal locus would provide stronger evidence.

4. The conclusions in the final section of the manuscript about how TA systems influence genetic diversity are not convincing. In Fig 7, sept-1(-) has a slightly higher rate of polymorphisms at the sept-1/zina-1 locus compared to sept-1(+), yet there is an even larger increase in polymorphisms further to the right, away from the locus at Mb 20.59-20.62. But at Mb 20.50-20.53 (between sept-1/zina-1 and the peak at Mb 20.60), sept-1(+) has higher polymorphisms than sept-1(-). It is unclear whether any of these effects are statistically significant. In fact, the absence of sup-35 appears to have a greater effect on polymorphisms at the sept-1/zina-1 locus than the absence of sept-1. The analysis of Tajima's D statistic is also unconvincing. As with the analysis of polymorphism rate, there is no statistical analysis to determine whether the small effects seen are statistically significant. In fact, if anything, sup-35(-) appears to have a more negative Tajima's D than sup-35(+) near the sup-35/pha-1 locus which is the opposite of what is stated in lines 357-359, "Supporting this idea, we found more negative Tajima's D in the region linked to sept-1(+) or sup-35(+) compared to the same region in strains without the TA system." Overall, the data presented here do not support the conclusion that the presence of a TA leads to reduced diversity.

5. In general, the Methods sections are brief and not very specific. The following Methods sections should be improved:

a. Concentrations of DNAs injected to make transgenic lines should be provided. This information could be added to Table S2. Co-injection markers should be specified.

b. For CRISPR, more details should be provided, including concentrations of reagents and what co-CRISPR marker was used. Primers used to generate repair templates do not seem to be provided in Table S4. Also, it is stated that PCR genotyping was used to screen for CRISPR edits, but it is unclear what primers were used. These primers do not seem to be provided in Table S4. There are some genotyping primers shown in Table S4, but these are presumed to be just the primers used to genotype the sept-1, sept-2, and zina-1 alleles, not for screening CRISPR edits. What these are should be clarified.

c. Heat-shock temperature is not provided.

d. Methods of cloning and generating DNA constructs are not described fully. What cloning methods were used? Also, cloning primers should be listed in Table S4.

e. Antibody staining: concentrations of antibodies should be provided as well as the buffer they are diluted into.

f. smFISH: concentrations and sequences of probes should be provided.

g. RNAseq: description of how worms were grown and RNA isolated should be provided.

Minor points

1. The sept-1/zina-1 TA has also been reported by another lab (Zdraljevic et al., PMID: 39605437) who called it mll-1/smll-1. At two points, (lines 185 & 365), sept-1/zina-1 is described as "likely the same" as mll-1/smll-1. Use of the term "likely" is confusing, as the two papers identify the same genes.

2. A rather lengthy section of the results is devoted to RNA editing in the 3'UTR of the sept-1 mRNA. This section is tangential to the main storyline and ultimately concludes with a negative result: RNA editing has little effect on the sept-1 mRNA stability and is not required for toxicity. We feel that this section could be dramatically shortened, with the data in a supplementary figure where they won't distract from the main narrative.

3. Discussion, Lines 387-391. This paragraph makes unsupported claims about the promoter of sept-1 being stronger than sept-2 (see point #3 above), and the importance of the sept-1 3'UTR stem-loop and RNA-editing to stabilizing sept-1 mRNA. The data however show that RNA editing does not significantly stabilize the sept-1 mRNA and whether the stem-loop is stabilizing is not addressed. We would suggest cutting this paragraph.

4. Discussion, Lines 392-401. This is a highly speculative paragraph that makes assertions based on data not described in the Results sections. Line 393: it is asserted that ZINA-1 is not localized in the nucleus, but this has not been convincingly demonstrated. The images in Fig 5A&B are not shown at the resolution needed to make such a claim. Line 397: it is asserted that GFP::ZINA-1 forms aggregates. It is unclear what is considered an aggregate in Fig 5A&B - arrows in these figures would help. There are perhaps some punctae, but proteins can appear punctate for reasons other than aggregation (e.g. membrane association). Additionally, zinc-finger proteins are not exclusively DNA or RNA-binding proteins as implied here. They can also bind other proteins and function in a wide range of processes (see PMID 29152378 for example). Thus, ZINA-1 could have a number of potential antidote functions outside the nucleus that don't involve RNAs. Based on the data, hypothesizing that ZINA-1 is involved in liquid-liquid phase separation is highly speculative.

5. sept-1p shows somatic expression in the intestine and pharynx in both L1 larvae and adults (Fig S5). This is not discussed. Is it possible that, in addition to maternally-delivered sept-1, somatic expression also contributes to toxicity? Also, is the endogenously-tagged sept-1::tagRFP expressed in larvae and adults? If so, where does the protein localize?

6. For the crosses in Fig 1, it would be useful to show the parental generation cross used to generate the N2/XZ1516 hybrid -- i.e. which parent was male and which was hermaphrodite? Does the direction of the parental cross matter? Given that some maternally inherited incompatibility genes show a maternal cytoplasmic pattern of inheritance, that possibility should be accounted for here.

7. Line 163. What is a SEP domain and generally what do they do? Providing a domain map of SEPT-1 would be useful.

8. Outside of C. elegans, are there any homologs of sept-1 and zina-1?

9. Lines 404-406: "Hawaiian_2 strains represent a transition period when the sept-1/zina-1 was gradually lost through the accumulation of missense mutations in the sept-1 coding sequences." This implies that these strains have an intermediate number of missense variants. Is this true?

10. Lines 414-416: as an alternative to the idea that peel-1/zeel-1 emerged early in the Hawaiian lineage but didn't propagate, is it possible that peel-1/zeel-1 did not exist in the Hawaiian ancestor, but instead was acquired later in certain Hawaiian strains by mating and recombination with peel-1/zeel-1 strains (i.e. this chromosomal region was transferred while the rest of the genome remained Hawaiian?). It seems that it is tricky to make strong conclusions about the age of a chromosomal segment from the overall phylogenetic tree, because the phylogeny of specific chromosomes or genes may not match the overall tree.

11. Is sept-2 the proper nomenclature for the sept-1 ortholog in N2? They are both the same gene in the same species, only with some sequence divergence. It seems like calling this gene sept-1(N2) might be more appropriate.

12. Line 290 and Figure 5A: Though GFP::ZINA-1 co-localizes with ges-1p::RFP, it does not show "clear enrichment." This should be toned down.

13. Line 300 & Fig 5C legend: why are these worms described as "dried up"? In the classic rod-like larval arrest, worms are typically described as "fluid-filled."

14. Figures or legends should include N of worms scored.

15. All micrograph scale bars should be defined in the figure legends. For example: Fig 3D, Fig 4A, Fig 5B-E.

16. In figure panels with multiple Chi-square tests, there should be statistical correction for multiple comparisons.

17. Figure 6: there appear to be a couple instances where peel-1 is present while zeel-1 is absent. Could the authors comment on this, since peel-1(+)/zeel-1(-) animals should not be viable.

18. Figure 6: it would be useful to provide strain names in a supplementary Table for the 611 worm strains and their TA genotypes.

19. There should be a key for Table S1, explaining what each of the column headings means. Many of these are nonintuitive.

20. In Table S4, CRISPR repair templates should be briefly described, not just "recombinant DNA."

21. Table S5 should list the vector backbones of the plasmid constructs.

22. In many of the micrographs, it would help non-worm readers if the images included arrows pointing to specific features of interest. For example, pointing out the deformed pharynx in Fig 1A.

23. Figure 1A: for clarity, the figure should say "Type I" or "Type II," not "Arrested larva-I" or "Arrested larva-II"

24. Figure 1B-F: a Punnett square showing the result of the cross and how/why each case of deviance from 75% marker is informative would be useful, especially for readers from non-genetics backgrounds.

25. In Fig S6, shading of identical and similar residues would help to visualize the alignment.

26. The use of a white font on a gray background in Fig 7A is hard to read.

27. In Fig 7B (left panel), it would help to use colors that are more different than blue and green.

28. In Fig S1D & E: why are there male symbols in the final generation when worms were scored? Were only male worms scored?

29. Line 125: make it clear that 15-22 Mb refers to chromosomal position, not the size of the mapped region because this was confusing when first read.

30. Line 141: change "The rest exons…" to "The rest of the exons…"

31. Line 221: "allowed sept-2 to be expressed and its toxicity be revealed." The writing here is confusing and makes it sound like sept-2 is toxic, when in fact, the opposite is concluded. Better would be "allowed sept-2 to be expressed and its possible toxicity to be tested."

32. Line 247-248: sept-1 mRNA being deposited into oocyte is also reported by Zdraljevic et al., and this should be noted as a similarity between the studies.

33. Line 299: DIC should be spelled out.

34. Lines 354 and 359: include which panel of Figure 7.

35. Line 381: is it correct to call this the "endogenous RNAi pathway"?

36. Line 782: include reference for Bayes Empirical Bayes analysis in the figure text. This method should also be described in the Methods section.

37. There are several incorrect figure call-outs:

line 179: not Fig S2C

line 303: should include Fig 5E

lines 321 & 330: there are no Fig 6A & B, just Fig 6.

38. There are a number of typos:

line 38: should be "addiction"

line 383: should be "between SEPT-1 and SEPT-2"

line 451: should be "Center"

line 520: should be "IPTG"

line 538: should be "substitution"

line 575: should be "Leica"

line 581: should be "strain"

line 594: the period should be changed to a comma: "…wild isolates, we combined…".

Reviewed (and signed) by Daniel Park and Michael Ailion

Decision Letter 2

Roland G Roberts

2 Jul 2026

Dear Dr Zheng,

Thank you for your patience while we considered your revised manuscript "sept-1/zina-1 is an Ancient Toxin-Antidote System in Caenorhabditis elegans" for publication as a Research Article at PLOS Biology. This revised version of your manuscript has been evaluated by the PLOS Biology editors and the Academic Editor.

Based on our Academic Editor's assessment of your revision, we are likely to accept this manuscript for publication, provided you satisfactorily address the following data and other policy-related requests.

IMPORTANT - please attend to the following:

a) Please address my Data Policy requests below; specifically, we need you to supply the numerical values underlying Figs 1DEFGHI, 2DEF, 3ACDEGH, 4D, S2C, S3A, S5ACD S6AB, S7 (treefile), either as a supplementary data file or as a permanent DOI’d deposition.

b) Please cite the location of the data clearly in all relevant main and supplementary Figure legends, e.g. “The data underlying this Figure can be found in S1 Data” or “The data underlying this Figure can be found in https://zenodo.org/records/"; also update your Data Availability Statement accordingly.

c) Please make any custom code available, either as a supplementary file or as part of your data deposition.

d) Please include the URLs of your funders in the Financial Disclosure statement.

As you address these items, please take this last chance to review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the cover letter that accompanies your revised manuscript.

In addition to these revisions, you may need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests shortly. If you do not receive a separate email within a few days, please assume that checks have been completed, and no additional changes are required.

We expect to receive your revised manuscript within two weeks.

To submit your revision, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' to find your submission record. Your revised submission must include the following:

- a cover letter that should detail your responses to any editorial requests, if applicable, and whether changes have been made to the reference list

- a Response to Reviewers file that provides a detailed response to the reviewers' comments (if applicable, if not applicable please do not delete your existing 'Response to Reviewers' file.)

- a track-changes file indicating any changes that you have made to the manuscript.

NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines:

https://journals.plos.org/plosbiology/s/supporting-information

*Published Peer Review History*

Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://plos.org/published-peer-review-history/

*Press*

Should you, your institution's press office or the journal office choose to press release your paper, please ensure you have opted out of Early Article Posting on the submission form. We ask that you notify us as soon as possible if you or your institution is planning to press release the article.

*Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please do not hesitate to contact me should you have any questions.

Sincerely,

Roli Roberts

Roland Roberts, PhD

Senior Editor

rroberts@plos.org

PLOS Biology

------------------------------------------------------------------------

DATA POLICY:

You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: http://journals.plos.org/plosbiology/s/data-availability. For more information, please also see this editorial: http://dx.doi.org/10.1371/journal.pbio.1001797

Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms:

1) Supplementary files (e.g., excel). Please ensure that all data files are uploaded as 'Supporting Information' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore).

2) Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication.

Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels as they are essential for readers to assess your analysis and to reproduce it: Figs 1DEFGHI, 2DEF, 3ACDEGH, 4D, S2C, S3A, S5ACD S6AB, S7 (treefile). NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values).

IMPORTANT: Please also ensure that figure legends in your manuscript include information on where the underlying data can be found, and ensure your supplemental data file/s has a legend.

Please ensure that your Data Statement in the submission system accurately describes where your data can be found.

------------------------------------------------------------------------

CODE POLICY

Per journal policy, if you have generated any custom code during the course of this investigation, please make it available without restrictions. Please ensure that the code is sufficiently well documented and reusable, and that your Data Statement in the Editorial Manager submission system accurately describes where your code can be found. More information on our Code Policy, what and how to share can be found here: https://journals.plos.org/plosbiology/s/code-availability

Please note that we cannot accept sole deposition of code in GitHub, as this could be changed after publication. However, you can archive this version of your publicly available GitHub code to Zenodo. Once you do this, it will generate a DOI number, which you will need to provide in the Data Accessibility Statement (you are welcome to also provide the GitHub access information). See the process for doing this here: https://docs.github.com/en/repositories/archiving-a-github-repository/referencing-and-citing-content

------------------------------------------------------------------------

BLOT AND GEL REPORTING REQUIREMENTS:

We require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare and upload them now. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements

------------------------------------------------------------------------

DATA NOT SHOWN?

- Please note that per journal policy, we do not allow the mention of "data not shown", "personal communication", "manuscript in preparation" or other references to data that is not publicly available or contained within this manuscript. Please either remove mention of these data or provide figures presenting the results and the data underlying the figure(s).

------------------------------------------------------------------------

Decision Letter 3

Roland G Roberts

13 Jul 2026

Dear Dr Zheng,

Thank you for the submission of your revised Research Article "sept-1/zina-1 is an Ancient Toxin-Antidote System in Caenorhabditis elegans" for publication in PLOS Biology. On behalf of my colleagues and the Academic Editor, Peter Sarkies, I'm pleased to say that we can in principle accept your manuscript for publication, provided you address any remaining formatting and reporting issues. These will be detailed in an email you should receive within 2-3 business days from our colleagues in the journal operations team; no action is required from you until then. Please note that we will not be able to formally accept your manuscript and schedule it for publication until you have completed any requested changes.

IMPORTANT: I've asked my colleagues to include the following request alongside their own: "Many thanks for suppying your code in Github. However, because Github depositions can be readily changed or deleted, please make a permanent DOI’d copy (e.g. in Zenodo) and provide this URL in your Data Availability Statement."

Please take a minute to log into Editorial Manager at http://www.editorialmanager.com/pbiology/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production process.

PRESS: We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with biologypress@plos.org. If you have previously opted in to the early version process, we ask that you notify us immediately of any press plans so that we may opt out on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/.

Thank you again for choosing PLOS Biology for publication and supporting Open Access publishing. We look forward to publishing your study.

Sincerely,

Roli Roberts

Roland G Roberts, PhD, PhD

Senior Editor

PLOS Biology

rroberts@plos.org

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. sup-35/pha-1 is inactivated in XZ1516.

    (A) A comparison of the zeel-1/peel-1 locus between XZ1516 and N2 shows good conservation of synteny (gray lines). (B) A comparison of the sup-35/pha-1 locus between XZ1516 and N2 shows several genomic rearrangement events. pha-1 is split into two short ORFs (pha-1#1 and pha-1#2) due to a deletion event in XZ1516. This split likely inactivated the pha-1 gene function. sup-35 is duplicated into sup-35#1, sup-35#2, and sup-35#3 due to duplication and inversion events but all three copies have shown significant sequence divergence from sup-35(N2), which likely leads to the loss of toxicity (see S8 Fig for details). sup-35 also shows similarity to Y48A6C.4, which is duplicated and split into three copies in XZ1516. (C) The sup-35(unk210) allele in N2 strain created in this study through CRISPR/Cas9-mediated gene editing. Premature stops were inserted into the first exon to inactivate the gene. (D) Cross schemes used to test the inheritance pattern of the chrV-linked novel TA in XZ1516. The black bars indicate the N2 chrV carrying a TagRFP-expressing fluorescent reporter (pink). The brown bars indicate the homologous XZ1516 chrV carrying a novel TA system. The results of the crosses indicate the presence of maternal deposit of the XZ1516-derived toxin. Among the alive progeny, we only scored the males, which are for sure the cross-progeny. (E) The result of the cross indicates the lack of paternal deposit of the XZ1516-derived toxin.

    (TIF)

    pbio.3003563.s001.tif (1.5MB, tif)
    S2 Fig. Identification of the sept-1 and zina-1 as the toxin and antidote genes.

    (A) XZ1516 animals treated with bacteria expressing dsRNA against zina-1 or carrying the empty RNAi vector L4440. Scale bars, 20 μm. (B) Gene structures of sept-1(XZ1516) long and short isoforms and the molecular lesions of the various alleles. (C) The count of reads that align to the region that is specific for the long isoform and the region shared by long and short isoforms. (D) The molecular lesion of the zina-1(unk221) null allele. Premature stops (red) were inserted into exon 3 using CRISPR/Cas9-mediated gene editing. The data underlying this Figure can be found in S1 Data.

    (TIF)

    pbio.3003563.s002.tif (1.5MB, tif)
    S3 Fig. sept-1/zina-1 is a maternally inherited TA system.

    (A) Cross schemes and the results of genotyping the F2 progeny. XZ1516 sept-1(unk192) mutants were used for “T-” and sept-1(unk192) zina-1(unk221) mutants were used as “TA-”. The introgressed strain CGZ1589 was used as N2 (TA). The toxin sept-1 was genotyped, and its presence in the genome of the F2 progeny was considered T+. (B) Two crosses that confirmed the maternal deposition of the SEPT-1(XZ1516) toxin by genotyping the offspring. In the left cross, 100% of the progeny were alive and ~50% carry the T+ genotype. In the right cross, only ~50% of the progeny were alive and they all carry the T+ genotype. Some images were created using Biorender. The data underlying this Figure can be found in S1 Data. Part of the Figure was created in BioRender. Zheng, C. (2026) https://BioRender.com/5fjhayv.

    (TIF)

    pbio.3003563.s003.tif (695.9KB, tif)
    S4 Fig. Genomic editing of the sept-1/zina-1 locus.

    (A) The zina-1(unk232) allele denotated as zina-1(N2*) was constructed by inserting 190-bp sequence into the exon 3 of zina-1(N2ψ). These sequences were taken from the exon 3 and exon 4 of zina-1(XZ1516). (B) The schematic presentation of the unkSi32[hsp16.41::sept-1(XZ1516)::tbb-2 3′UTR], unkSi18[hsp16.41::sept-1(N2)::tbb-2 3′UTR], unkSi42[hsp-16.41::sept-1(XZ1516)::2xHA::tbb-2_3UTR], and unkSi46[hsp-16.41::sept-1(N2)::2xHA::tbb-2_3UTR], which are single-copy insertions into the chrII: kstSi42 locus of the CFJ42 strain (N2 background) using the MosTI method. (C) Editing of the endogenous sept-1 locus in XZ1516 and N2. The coding sequence was replaced by the desired sequence using CRISPR/Cas9 gene editing. (D) The expression of sept-1 mRNA detected by RT-PCR in various animals. ama-1 served as an internal control.

    (TIF)

    pbio.3003563.s004.tif (1.3MB, tif)
    S5 Fig. Induced expression of sept-1(XZ1516) generates stronger toxicity than sept-1(N2).

    (A) RT-qPCR results showed the fold change of the induced expression of sept-1(XZ1516) and sept-1(N2) from the single-copy transgenes unkSi32 and unkSi18, respectively, at 2 hours after the 33 °C heat-shock of various duration. Fold change was calculated in comparison with the animals that did not undergo heat-shock. (B) Western blot results using anti-HA antibodies showed the expression of SEPT-1(XZ1516)::HA and SEPT-1(N2)::HA proteins from the unkSi42 and unkSi46 transgene, respectively, at 2 or 4 hours after a 30-min or 60-min heat-shock. Tubulin is used as a loading control. (C) Percentage of animals that survived 24 hours after the heat-shock at L1 or L4 stage. Three to five replicates were made for each condition with ~100 animals analyzed. Double asterisks indicate p < 0.01 in a Tukey’s test comparing the transgenic animals with the wild type or between the two transgenes (unkSi32 and unkSi18 were used). (D) L4-stage animals were heat-shocked at 33 °C for 60 min and then imaged at 24 hours after the heat-shock. Scale bars, 10 μm. The dorsoventral width (indicated by the lines) of the intestine was measured and normalized to the width of the worm body. Around 40 animals were analyzed. The data underlying this Figure can be found in S1 Data.

    (TIF)

    pbio.3003563.s005.tif (3.8MB, tif)
    S6 Fig. Somatic expression of the sept-1(XZ1516) and sept-1(N2) genes.

    Expression patterns of sept-1(XZ1516)p::TagRFP and sept-1(N2)p::TagRFP in the XZ1516 (A) and N2 backgrounds (B). The DNA constructs were injected into the two strains at the same concentrations, and the stable lines were imaged at different stages. Quantifications of the fluorescent intensity are shown in the bar graphs on the right. Expression of sept-1(XZ1516)p::TagRFP was stronger than sept-1(N2)p::TagRFP in both backgrounds. Scale bars, 20 μm. The data underlying this Figure can be found in S1 Data.

    (TIF)

    pbio.3003563.s006.tif (3.8MB, tif)
    S7 Fig. Distribution of the three TA systems in C. elegans wild isolates.

    A phylogenetic tree of 611 C. elegans wild isotypes constructed using optimal Bayesian models selected by ModelFinder based on the CDS of 4,736 single-copy genes. The presence and absence of the toxin and antidote genes were called using the criteria listed in the Materials and methods. Strains that were isolated from Hawaiian Islands are labeled in orange. The group each strain is assigned to is also shown. The tree file underlying this Figure can be found in S1 Data.

    (TIF)

    pbio.3003563.s007.tif (2.3MB, tif)
    S8 Fig. Divergence of sup-35 among the C. elegans wild isolates.

    (A) A comparison of the sup-35/pha-1 locus between DL238 and N2 shows the deletion of the pha-1 gene in DL238. An inversion event caused divergence of sup-35. However, unlike previously reported, sup-35 is not pseudogenized in DL238. An ORF can be constructed from the sup-35 gene in DL238. (B) Pairwise alignment of SUP-35(N2) and SUP-35(DL238). (C) A phylogenetic tree of rmd-1/2, sup-35, and Y48A6C.4 homologs from various C. elegans wild isolates and other nematodes. The location of sup-35#1~3 and Y48A6C.4#1~3 in XZ1516 genome can be found in S1 Fig.

    (TIF)

    pbio.3003563.s008.tif (2.4MB, tif)
    S1 Table. Candidate genes for the antidote that were tested by RNAi.

    Column A to E show the names and coordinates of the genes in XZ1516 genome. Column F shows the transcript name of the N2 gene aligned to the XZ1516 gene. Columns G to O show the alignment details with the XZ1516 gene as the query (e.g., Qstart and Qend) and the N2 gene as the target sequence (e.g., Sstart and Send). The percentage of identity for the alignment is shown in column O. Column P shows the RNA expression level of the candidate gene in XZ1516. Column S shows whether the RNAi of the gene induced the rod-like phenotype. Columns T and U list the primers used to amplify the target XZ1516 gene, and the amplified DNA fragments were inserted into L4440 for feeding RNAi.

    (XLSX)

    pbio.3003563.s009.xlsx (15.9KB, xlsx)
    S2 Table. Distribution of the three TA systems in C. elegans wild isolates.

    Detailed strain information for Figs 6A and S7. The number of strains and the number of Hawaiian strains in the group were shown. Groups 1–14 are Hawaiian groups because ≥ 50% of the strains are Hawaiian strains. Groups 15–24 are assigned as non-Hawaiian groups. The number of minority strains (i.e., non-Hawaiian strains in a Hawaiian group or Hawaiian strains in a non-Hawaiian group) is shown in the “Minority” column. The calling of the genotypes is described in Materials and methods. “N.D.” means the genotypes of the TA systems are unknown.

    (XLSX)

    pbio.3003563.s010.xlsx (14.2KB, xlsx)
    S3 Table. A list of strains used in this study.

    (XLSX)

    pbio.3003563.s011.xlsx (11.4KB, xlsx)
    S4 Table. A list of software used in this study.

    (XLSX)

    pbio.3003563.s012.xlsx (12.6KB, xlsx)
    S5 Table. A list of primers used in this study.

    (XLSX)

    pbio.3003563.s013.xlsx (11.6KB, xlsx)
    S6 Table. A list of DNA constructs used in this study.

    (XLSX)

    pbio.3003563.s014.xlsx (45KB, xlsx)
    S7 Table. Details of the CRISPR alleles generated in this study.

    (XLSX)

    pbio.3003563.s015.xlsx (14KB, xlsx)
    S8 Table. The sequence of the smFISH probes against sept-1.

    (XLSX)

    pbio.3003563.s016.xlsx (10.5KB, xlsx)
    S1 Data. Numeric data underlying all main and supporting figures.

    (XLSX)

    pbio.3003563.s017.xlsx (7.6MB, xlsx)
    S1 Raw Images. Original gel and blot images for S4D and S5B Figs.

    (PDF)

    pbio.3003563.s018.pdf (592KB, pdf)
    Attachment

    Submitted filename: Point to point response.docx

    pbio.3003563.s021.docx (46.2KB, docx)
    Attachment

    Submitted filename: Point_to_point_response_auresp_3.docx

    pbio.3003563.s022.docx (46.2KB, docx)

    Data Availability Statement

    Genomic DNA sequencing data for the introgressed strain CGZ1589 and RNA sequencing data for XZ1516, CGZ1698, and CGZ2735 were uploaded to NCBI Sequence Read Archive (SRA) under the accession number PRJNA1359096. The reassembled chromosome-level genomes of the C. elegans wild isolates were uploaded to NCBI under the accession number PRJNA1477378. All individual numerical values underlying the figures are provided in the Supporting information file S1 Data. Original gel and blot images can be found in S1 Raw Images. All analysis scripts used in this study are publicly available at Zenodo (https://doi.org/10.5281/zenodo.21353375).


    Articles from PLOS Biology are provided here courtesy of PLOS

    RESOURCES